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Type 2 diabetes is a population health problem and a leading cause of mortality in the 
United States. The complications and comorbidities associated with diabetes cause a 
financial and resource burden on the healthcare system and negative mental and physical 
health outcomes for the individuals living with the disease. The clinical practice problem 
addressed by this project was glycemic control following an orthopedic surgery requiring 
hospitalization. The project was informed by the chronic care model, which emphasizes 
the need for a whole system, interdisciplinary team approach to disease management and 
prevention of complications. To analyze the practice problem and create an evidence-
based clinical practice guideline to direct patient care, a literature review was completed. 
Literature was reviewed and graded using the Oxford Centre for Evidence-Based 
Medicine Levels of Evidence. Professional organizations’ guidelines and scholarly 
publications were also reviewed in developing the guideline. Central themes from the 
literature review were translated into the clinical practice guideline and included the 
importance of long-term preoperative glycemic control, patients’ skills for self-
management, and mental health evaluation and support of patients. To ensure the 
appropriateness of the clinical practice guideline for translation into practice, the AGREE 
II tool was applied by the author in the guideline development and used by the project 
team in evaluation of the guideline for adoption. Improving postoperative glycemic 
control for patients living with type 2 diabetes supports social change by improving the 
patients’ ability to contribute to society, decreasing the healthcare burden, and addressing 
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Section 1: Nature of the Project 
Introduction 
In the United States, as of 2015, 30.3 million people are affected by diabetes and 
an estimated 95% of these cases are classified as type 2 diabetes (American Diabetes 
Association [ADA], 2019a). Data show that individuals 65 years of age and older have 
the highest prevalence of this diagnosis (ADA, 2019a). However, childhood and young 
adults are receiving type 2 diabetes diagnoses at an alarmingly high rate due to obesity, 
poor lifestyle choices, and genetic factors (Dutta & Ghosh, 2019). In the United States, as 
of 2017, the annual cost of diabetes was an estimated $327 billion (ADA, 2019a). As of 
2015, it was the seventh leading cause of death (ADA, 2019a). Public health officials 
estimate that type 2 diabetes diagnosis will continually rise at a faster rate, leading to 
financial burdens that will bankrupt insurance companies and healthcare institutions 
(Maa, 2017).  
Type 2 diabetes is a chronic disease with known pathophysiologic and metabolic 
changes that contribute to hyperglycemia (Hurtado & Vella, 2019). The pathophysiologic 
changes are referred to as the “ominous octet,” as first described by Dr. Ralph DeFranzo, 
an esteemed endocrinologist hoping to identify the defects contributing to type 2 diabetes 
in order to improve treatment (DeFranzo, Elder, & Abdul-Ghani, 2013). The ominous 
octet identifies the following body malfunctions: (a) inadequate release of the hormone 
glucagon-like peptide 1 (GLP-1) from the gut, (b) poor release of insulin from the beta 
cells in the pancreas, (c) too much glucagon release from the alpha cells of the pancreas, 





production of excess sugar in response to glucagon production and insulin resistance, (f) 
lack of GLP-1 response by the brain and appetite dysregulation, (g) the insulin resistant 
state of fat cells, and (h) excessive reabsorption of sugar from the kidneys returning to the 
bloodstream (DeFranzo et al., 2013). These malfunctions contribute to hyperglycemia 
and a type 2 diabetes diagnosis.  
Many complications and comorbidities are associated with a type 2 diabetes 
diagnosis. Type 2 diabetes is known to cause both microvascular and macrovascular 
conditions (Hayfron-Benjamin et al., 2019). Microvascular complications include 
retinopathy which contributes to blindness, neuropathy which contributes to amputations, 
and nephropathy which contributes to chronic kidney disease (Hayfron-Benjamin et al., 
2019). Macrovascular complications include coronary artery disease, increased risk of 
myocardial infarction (MI), peripheral vascular disease, and increased risk of 
cerebrovascular accident (Hayfron-Benjamin et al., 2019). Common comorbidities 
associated with a type 2 diabetes diagnosis include obesity, hypertension, and 
hyperlipidemia (Nowakowska et al., 2019). Researchers have also shown correlations 
between type 2 diabetes, decreased cognitive functioning, and dementia (Simo, Ciudin, 
Sino-Servat, & Hernandez, 2017).  
Type 2 diabetes has also been associated with poor quality of life and increased 
rates of depression (Gómez-Pimienta et al., 2019). Individuals with a type 2 diabetes 
diagnosis are more likely to suffer from multiple medical conditions and have lower 





type 2 diabetes often face burnout as the disease requires a great amount of self-care and 
self-efficacy (Van Smoorenburg et al., 2019).  
Type 2 diabetes management requires several pharmacologic and non-
pharmacologic interventions (ADA, 2019b). In recent years, the cost of insulin, 
injectables, and oral anti-hyperglycemic agents have received much attention (Meng et 
al., 2017). The cost of these medications is currently not restricted and, depending on 
insurance coverage and other factors, these medications may be unaffordable for some 
patients (Meng et al., 2017). Both the American Association of Clinical Endocrinologists 
(AACE, 2019b) and ADA (2019b) guidelines illustrate the potential need for three or 
more medications for the appropriate management of type 2 diabetes. The financial 
burden also extends to the healthcare systems and health insurance companies (Maa, 
2017).  
Nonpharmacological interventions for the treatment of type 2 diabetes may 
include diet, exercise, nutrition therapy, diabetes education, nicotine cessation, stress 
relief, and mental health wellness services (ADA, 2019b). These interventions are 
important for the treatment of type 2 diabetes and barriers should be eliminated. Many 
people associate healthy eating with high-cost foods, therefore, creating a barrier to 
healthy eating (Rehm, Monsivais, & Drewnowki, 2015). Food deserts, areas where 
certain foods, including fresh fruits and vegetables are not available, compound the 
difficulty of improved dietary habits (Schupp, 2019). Exercise requires a lifestyle change 





education and inability to motivate themselves to start an exercise regimen as barriers to 
beginning an exercise routine (Jalilian, et al., 2019). Poor exercise regimens may be 
associated with comorbidities, time limitations, cost, climate, and functional limitations 
(Korkiakangas et al., 2011). Stress relief and mental health in general are under discussed 
topics that may have an impact on glycemic control (Armani Kiam et al., 2018). Lack of 
mental health resources and stress management education reduce the ability of the person 
living with type 2 diabetes from using healthy coping mechanisms to help self-manage 
their disease (Armani Kiam et al., 2018). These barriers are especially to discuss and 
overcome prior to a surgical procedure.   
When speaking of postoperative outcomes, glycemic control is of importance. 
Surgical risks, including prolonged healing time and increased length of stay, are 
substantially higher when the 90-day average glucose measured via hemoglobin A1C 
(HgbA1C) is above 8% (Underwood et al., 2014). For this reason, many surgeons will 
not perform nonemergent surgery on a patient with an A1C above 8%. Such a delay in 
surgery could lead to prolonged pain, prolonged time away from work, decreased 
functioning and mobility, decreased ability to perform activities of daily living, 
depression, and poor perceived quality of life (Paul & Issac, 2018). Uncontrolled diabetes 
leads to poor outcomes such as longer hospital stays, infection, evisceration or wound 
opening, the need for ventilation, admission to the intensive care unit, and mortality 
(Yong et al., 2018). These delays contribute to prolonged time away from work, delayed 





need for pain management therapies, and decreased perceived quality of life (Yong et al., 
2018). 
A Doctor of Nursing Practice (DNP) project calls for the standardization and 
utilization of a guideline to improve postoperative glycemic control in hospitalized 
patients living with type 2 diabetes following orthopedic surgery.  Because type 2 
diabetes affects a large percentage of the population, it is critical that healthcare providers 
are adequately equipped to assist in the management and prevention of postoperative 
complications related to glycemic control. From a social perspective, improving 
postoperative outcomes allows those with type 2 diabetes a faster return to work and 
normal functioning; it also limits the adverse effects on quality of life perception and 
depression (Paul & Issac, 2018). Nursing professionals need an improved knowledge 
base and a structured guideline to improve advocacy measures, teaching ability, and the 
care and treatment of patients living with type 2 diabetes.  
Problem Statement 
Type 2 diabetes is considered a problem of epidemic proportion and a large 
number of surgical patients have a diabetes diagnosis (ADA, 2019a). These patients are 
predisposed to altered glycemic control when undergoing a surgical procedure 
(Sudhakaran & Surami, 2015). Poor glycemic control is often found postoperatively 
because of preoperative changes in eating, medications and anesthesia agents, the 
withholding of insulin or alternate antihyperglycemic agents, as well as the metabolic 





& Surani, 2015). Hyperglycemia postoperatively contributes to an array of problems, 
including poor wound healing, higher rates of evisceration and infection, longer hospital 
stays, an increase in depression, and poorer perceptions of quality of life (Reategui et al., 
2015). Patients often must postpone return to work and have limited ability to perform 
activities of daily living (Akiboye & Rayman, 2017). Hyperglycemia has been noted to 
continue for 8 months postoperatively if untreated or undermanaged (Akiboye & 
Rayman, 2017). Prolonged hyperglycemia contributes to both microvascular and 
macrovascular complications, including retinopathy, neuropathy, nephropathy, coronary 
artery disease, myocardial infarction, cerebrovascular accident, and peripheral vascular 
disease (Hayfron-Benjamin et al., 2019). In addition, hyperglycemia may worsen 
comorbidities and increase the risk of infection (Hayfron-Benjamin et al., 2019).  
The problem of hyperglycemia following a surgical procedure is seen worldwide 
(Aklboye & Rayman, 2017). Delays in hyperglycemia treatment contribute to poor 
outcomes (Akiboye & Rayman, 2017). Glycemic management requires specialized 
education and an extensive time commitment from the entire healthcare team to ensure 
optimal outcomes (Sabione et al., 2018). For this reason, utilization of appropriate 
published guidelines that are evidence based, such as those established by the American 
Diabetes Association (2019), is critical. Therefore, the focus of the project was to 
synthesize the current research and guidelines issued by specialized organizations, 
including the ADA (2019b), into a practice guideline. The guideline outlines 





diabetes and who remain in the hospital after an orthopedic procedure. The aim of the 
DNP project was to analyze and appraise the research critically to ensure evidence-based 
practice methods are used and updated continually. 
Purpose Statement 
To enhance nursing practice, this project focused on the development of a clinical 
practice guideline that synthesized the recommendations and guidelines issued by 
reputable sources, which included, but were not limited to, the ADA (2019b), AACE 
(2019a), and the Endocrine Society (Umpierrez et al., 2012). The guideline should be 
used by all inpatient healthcare providers to ensure appropriate glycemic management of 
the patient with type 2 diabetes following an orthopedic surgical procedure requiring an 
inpatient stay. Nurses in particular should be aware of the evidence and guidelines to 
improve patient care and outcomes. Several evidence-based guidelines have been issued 
by reputable organizations, including the Endocrine Society (Umpierrez et al., 2012), 
ADA (2019b), and AACE (2019a). However, a synthesis and cohesive report of these 
guidelines would allow for improved application consistency (Patrik & Wyckoff, 2018). 
Additionally, continued review of research sources should be completed to ensure 
continued use of the most up-to-date, high-quality research (Breneman et al., 2015). The 
synthesis of the literature, recommendations, and guidelines will create a clear and 
concise guide that is evidence based and contains the highest quality research. A clinical 





current best practice standards as well as to reduce the gaps and disharmony of care 
(Patrick & Wyckoff, 2018).  
Nature of the Doctoral Project 
 Project completion required a robust literature review with great attention to 
research validity. The research, current guidelines, and literature will be analyzed 
extensively to ensure high quality research. The research findings were translated to fit 
the needs of the population: patients with type 2 diabetes postoperatively, who require an 
inpatient stay following an orthopedic procedure. A guideline was created by 
synthesizing the current guidelines as well as published literature, including specific 
details for postoperative patients. The synthesis allowed for creation of a clinical practice 
guideline that may be utilized within the clinical settings. This guideline is meant to be 
used by all nurses caring for the type 2 diabetic patient following an orthopedic surgery 
requiring an inpatient stay. It shall serve as a framework for glycemic management 
leading to improvements in perceived quality of life.  
Significance 
Type 2 diabetes is a significant problem in the United States, affecting nearly 30 
million people with an estimated annual cost of $327 billion as of 2015 (ADA, 2019a). 
The comorbidities and complications associated with type 2 diabetes increase the 
financial burden associated with the diagnosis and the complications following an 
orthopedic surgery including longer hospital stays, delays from work, and infections 





orthopedic surgery, confront many challenges that may decrease their perceptions of 
quality of life (Yong et al., 2018).  
Walden University (2019) established a mission to ensure that doctoral projects 
are focused on social change that allows for improvements and maintainable progression 
for society and the professions. This social change is expected to come from evidence 
and research to ensure the highest quality improvements (Walden University, 2019). 
Based on the research, poor postoperative outcomes related to type 2 diabetes have a 
grave effect on the individual as well as the society (Akiboye & Rayman, 2017).  
Therefore, improvements in outcomes may have a positive benefit on society.             
With this project, the profession of nursing will be afforded the opportunity to 
continue to grow and develop practice guidelines and ensure the appropriate use of 
evidence-based standards to ensure high-quality patient care. Ensuring that an 
established guideline can be translated into practice allows for continued development of 
the profession and positive societal impacts, including improvements in quality, 
evidence-based care. Guidelines are often lengthy and filled with specialty jargon that is 
difficult to read and understand (Guo et al., 2016). Providing a synthesis of the 
guidelines established by the ADA (2019b) will improve nurses’ ability to use the 
guideline. Therefore, nurses will be able to carry out the guideline and improve the care 








Type 2 diabetes is a disease millions of Americans are currently living with. The 
potential postoperative complications of those living with type 2 diabetes are severe and 
could lead to decreased quality of life, depression, debility, and mortality. The established 
guidelines offered by the ADA, AACE, and Endocrine Society offer recommendations to 
decrease the risk of postoperative complications. However, many patients continue to 
suffer from an array of postoperative complications. Guidelines can be difficult to 
interpret into practice for a variety of reasons. Producing a clear synthesis of the current 
guidelines will contribute to an improved use of the guidelines and thus contribute to 
improved patient care, improved glycemic control, decreased risk of complications, and 
improvements in perceived quality of life. A clinical practice guideline may be best 
created utilizing a model or framework. The guideline is relevant to the local area and the 
nursing profession. The student and project team are necessary to ensure clinical practice 






Section 2: Background and Context 
Introduction 
Type 2 diabetes is a chronic, progressive disease that may lead to a multitude of 
complications and alter a patient’s ability to function (Hurtado & Vella, 2019). Therefore, 
adequate treatment is imperative (Akiboye & Rayman, 2017). A professional guideline 
for diabetes management across the lifespan and continuum of care is published by the 
ADA with annual updates (2019b). The publication includes guidance on management of 
diabetes during hospitalization (ADA, 2019b). Though diabetes requires a great deal of 
self-management, during times of surgery and hospitalization, the responsibility for 
glycemic control includes the healthcare team (Akiboye & Rayman, 2017). Therefore, it 
is essential to have an established guideline for use in these circumstances and to ensure 
that nurses are educated about the guidelines and recommendations so that they can 
advocate for optimal glycemic control (Akiboye & Rayman, 2017). In this section, I 
discuss the model that guided the development of the clinical practice guideline, the 
development of a clinical practice guideline, its relevance to nursing practice, the local 
background and context, and the role of the DNP student. 
Model 
Concepts are simple words or phrases that act as building blocks and are 
commonly used in the nursing profession to strategize, theorize, and analyze (McEwen & 
Wills, 2019). To further evaluate glycemic management following an orthopedic surgical 





able to analyze specific components of glycemic management and explore each 
component exclusively and thoroughly. Within the concept of glycemic management, 
postoperatively, nurses consider hypoglycemia and hyperglycemia as concepts, as well as 
barriers to management. Many other concepts and factors may be dissected to analyze the 
situation (Yong et al., 2018).  
Models serve as frameworks or guides to address health concerns (McEwen & 
Wills, 2019). Many models are used in the management of type 2 diabetes (Crowe, Jones, 
Stone, & Coe, 2019). Crowe et al. (2019) offer research showing the improved efficacy 
of nurse-led models for the improvement of glycemic control when compared to 
physician-led models. The chronic care model (CCM) depicts the need for a whole 
system, interdisciplinary team approach for the management of disease and prevention of 
complications (Zuccaro, 2015). Type 2 diabetes is a complex, chronic, and progressive 
disease requiring the expertise of the individual living with it (Yadmaa, Samoilova, & 
Koshevets, 2018). Self-management, as well as the ability to adapt and alter self-
management techniques for alternate situations, are imperative for successful disease 
management (Yadmaa, Samoilova, & Koshevets, 2018). The model concepts and tenets 
allow the application of the CCM in guideline development.  
Grover and Joshi (2014) wrote that the CCM includes consideration of the 
community, the health system, the person living with diabetes, and the ever-changing 
circumstances of life to ensure adequate care and prevention of complications and 





management, self-efficacy, community, expert, and interdisciplinary care team. The  
CCM focuses on entire entities, communities, healthcare systems, technological 
advances, and the changing times as these changes are known to affect the way in which 
care is delivered and diseases are self-managed. Additionally, the National Committee for 
Quality Assurance recognized the importance of the whole system and whole-body 
approach to ensure appropriate diabetes management. As diabetes management requires 
the person living with the disease, the community, the healthcare system, a network of 
medical and healthcare professionals, a wealth of education, and change adaptation skills, 
the CCM is a model that is essential to disease management at any stage of life and with 
any healthcare challenge, including postoperatively (Grover & Joshi, 2014).  
 The CCM may be used to assist with clinical practice guideline development as 
proposed in this project. To create a guideline for post-orthopedic procedure glycemic 
control, all stakeholders must be considered. The guideline must consider the effects of 
the guideline on the patient, nurses, the hospital, and the community as a whole because 
poor glycemic control and poor patient outcomes affect not only the patient, but also their 
family, friends, healthcare providers, healthcare system, and entire community (Funnell, 
2006; Paul & Issac, 2018). As guideline review and synthesis progresses, those affected 
will be kept at the forefront to ensure the guideline may positively impact patients 







Relevance to Nursing Practice 
 Diabetes is a disease that has reached epidemic proportion in the United States 
and according to the World Health Organization (WHO, 2016) incidence rates have 
quadrupled since 1980. In the United States, as of 2015, 30.3 million individuals were 
living with type 2 diabetes (CDC, 2017b). Of the 30.3 million people living with diabetes, 
7.2 million are undiagnosed and unaware of their diagnosis (ADA, 2019a). These 
individuals are of varying ethnicities, ages, socioeconomic classes, and areas of residence 
(CDC, 2017b). Of the United States population, 9.4% are living with diabetes (CDC, 
2017b). Of the individuals living with diabetes, 90% to 95% or approximately 28,785,000 
people have a type 2 diabetes diagnosis (WHO, 2019). Comparative data presented by the 
CDC (2017a) shows an increase incidence over time in the United States. The incidence 
rate of type 2 diabetes in adults was 2.62% in 1985, 3.30% in 1995, 5.61% in 2005, and 
7.4% in 2015. The largest incidence rate increase has been noted within the past decade 
and this trend is expected to continue. Above and beyond those diagnosed with or living 
with diabetes without awareness, 84.1 million people, 33.9% of adults living in the 
United States have prediabetes (CDC, 2017b).   
 CDC (2017b) data shows disparities are noted with type 2 diabetes. Age is a 
known health disparity in terms of type 2 diabetes. Prevalence of a diabetes diagnosis is 
highest in persons over the age of 45. The 2015 data provided by the CDC (2017b) 
showed 10.9 diabetes diagnoses per 1,000 individuals in the 45 to 64 age group. The 





rate of 9.1 diabetes diagnoses per 1,000 individuals. Although many reports suggest a 
higher incidence of young adults with a type 2 diabetes diagnosis, the 18–44 age group 
has a prevalence rate of 3.1 diagnoses per 1,000 individuals. Women and men do not 
have statistically significant differences in prevalence. The prevalence rate for women is 
6.8 per 1,000 individuals and the prevalence rate for men is 6.7 per 1,000 individuals. 
Disparities are also noted in educational backgrounds with higher prevalence rates of 
diabetes among those individuals having lower levels of educational attainment. The 
diabetes prevalence rate for individuals without a high school diploma is 12.6%, for 
individuals with a high school diploma the rate is 9.3%, and for individuals with a college 
degree the rate is 7.2%. 
 Disparities in ethnicity and residence are also noted. The CDC documented the 
prevalence rate of male American Indians and Alaskan Natives as 14.9% and of female 
American Indians and Alaskan Natives as 15.3%, which is the highest rate of all 
ethnicities. The Black, non-Hispanic prevalence rate is 12.2% for men and 13.2% for 
women, and the Hispanic prevalence rates for men is 12.6% and 11.7% for women. The 
prevalence rates for the Asian ethnicity is 9% for men and 7.3% for women. The White, 
non-Hispanic ethnicity has the lowest prevalence rate, 8.1% for men and 6.8% for 
women. Additionally, the CDC documented disparities in the United States based on 
residence and reported the highest prevalence rates are seen in the Appalachian areas and 





 The prevalence, increasing incidence, and epidemic proportion complicate disease 
management and directly affect the societal impact as well as the significance of the 
problem on the nursing profession. The complications and comorbidities associated with 
type 2 diabetes further contribute to the problem significance. A number of diseases and 
health ailments are associated with diabetes which include but are not limited to 
hypertensive disorders, cardiac disorders including the risk for cerebrovascular accident, 
myocardial infarction, cardiovascular disease, dyslipidemia, and hypertension, and 
obesity (Hayfron-Benjamin et al., 2019). Many comorbidities and complications arise for 
microvascular and macrovascular changes caused by hyperglycemia, which include 
diabetic retinopathy, nephropathy, neuropathy, blindness, infections, amputations, kidney 
disease, pregnancy complications, silent MIs, and cardiac death (Hayfron-Benjamin et al., 
2019). Heart disease is the number one killer of patients living with diabetes (Healthy 
People 2020, 2011). Per Healthy People 2020 (2011), diabetes is considered the leading 
cause of blindness, lower limb amputations, and renal failure. Type 2 diabetes and the 
complications and comorbidities associated with the condition have contributed to the 
financial burden of the illness as well. It is estimated that diabetes and diabetes related 
illness cost $245 billion annually in the United States.  
 It is also important to discuss the personal and social impact of type 2 diabetes. 
Yadmaa, Samoilova, and Koshevets (2018) offered the direct correlation between a type 
2 diabetes diagnosis and psychological maladaptation related to the required behavioral 





Diabetes Attitudes, Wellness, and Needs (DAWN) Study was conducted in 13 countries 
to evaluate the perceptions, desires, and needs of both individuals living with diabetes and 
individuals providing care to those living with diabetes (Funnell, 2006). The study 
published by Funnell (2006) had numerous participants which included 2,705 physicians, 
both specialists and generalists, 1,122 nurses working in various specialty and general 
areas, 5,104 patients living with type 1 diabetes, and 5,104 patients living with type 2 
diabetes. All participants were interviewed in some form to identify perceptions on self-
management ability, disease stressors, difficulties with treatment regimen, and medical-
patient relationship barriers.  
 The outcomes of the DAWN study published by Funnell (2006) were insightful 
and offered a great opportunity for improvement and change. In terms of self-
management, 16.2% of individuals in the study living with type 2 diabetes admitted to 
full compliance with dietary and exercise recommendations and other self-care behaviors. 
Physician responses estimated 2.9% self-management compliance rates among their 
patients living with type 2 diabetes. Of the patients surveyed living with diabetes, 85.2% 
admitted to high levels of disease distress at diagnosis and 41% of patients living with 
diabetes admitted to continued distress 15 years after diagnosis. The study also showed 
that only 10% of patients whom had experienced disease distress were evaluated or 
treated for the distress. Nurses in the study perceived higher rates of disease-related 
distress and were more likely to make the association between the distress and poor 





the United States were the least likely to refer patients to mental health services for 
disease distress. Likewise, physicians expressed their lack of knowledge regarding the 
psychological distress caused by outcomes and noted the relationship between 
psychological distress and poor patient outcomes.  
The DAWN study as published by Funnell (2006) explored perceptions of 
healthcare providers and potential barriers to glycemic control. The study showed that the 
patients with more complications self-reported poor relationships with healthcare 
providers and lack of access to resources. Most patients in the study reported they saw 
two or fewer healthcare professionals for diabetes management, meaning that few 
patients were appropriately referred to receive recommended vision screenings, 
education, primary care services, and specialty services. Additionally, nearly half of 
providers self-reported restricting medication use and insulin initiation as long as possible 
despite guidelines and recommendations. Overall, the DAWN study showed major 
barriers to the improvement of glycemic control in patients living with diabetes. Patients 
living with diabetes face many psychological barriers and are likely to suffer from disease 
distress that is not appropriately addressed or managed in many cases. The 
interdisciplinary team is not used effectively to ensure patients living with diabetes are 
appropriately monitored and prevention services are obtained. Perhaps most importantly, 
providers recognized the need to have a better understanding on the psychological effects 





 The DAWN2 study was conducted in 2011, published by Joensen et al. (2017) 
and evaluated patients living with diabetes, healthcare providers, and caregivers or family 
members of the patients living with type 2 diabetes. Study participants came from 17 
countries and 15,000 individuals living with type 1 and type 2 diabetes collectively were 
surveyed. Many of the results were quite similar to the DAWN study and indicated that 
13.8% of people living with diabetes had a concordant depression diagnosis and 44.6% 
reported disease distress. Self-reported opinions on quality of life showed 12.2% of study 
participants living with diabetes rated their quality of life as very poor or poor. Less than 
half of the surveyed participants reported attainment of diabetes education. DAWN2 
assessed the concerns of family members as well and found 35.3% of family members 
felt the diagnosis of diabetes was a burden, 61.3% of family members had continual fears 
of hypoglycemia, and 44.6% of family members felt distress and psychological changes 
because of their family members diabetes diagnosis. Like in the original DAWN study, 
healthcare professionals reported the need for improved diabetes education, the 
improvement in self-management capability, yet lacked the ability to assist with 
psychological distress or education. The DAWN2 study reiterated the high rate of disease 
distress, the negative glycemic outcomes related to diabetes distress, and the need for 
improvement in education as well as psychological management of distress.         
 Nurses play a unique role within the healthcare system and are often tasked with 
changing healthcare for the better. Often, nurses work directly with patients and are able 





Abma, 2019). These opportunities grant the nurse a unique perspective different from 
other healthcare professionals. Nurses have the ability to form a patient-nurse relationship 
built on trust and mutual respect, which allows the nurse the ability to further explore 
with the patient holistic health needs (Stuij et al., 2019). The nurse-patient relationship 
also allows for increases in patient confidence in their abilities to manage their own 
health (Davis, Johnson, McClory, & Warneck, 2019).  
 Nurses implement evidence-based practice to create guidelines, enforce standards, 
and elicit positive change and improved healthcare outcomes (Teodorowski, Cable, 
Kilburn, & Kennedy, 2019). These tasks are accomplished with application of several 
foundations of nursing practice, including advocacy, quality care, and education as 
established by the American Nurses Association (ANA, 2015). Research suggests that 
nurses are able to more effectively improve patient outcomes and elicit positive social 
change when their knowledge base is robust (Jones et al., 2018). As such, nurses educated 
on the recommendations and guidelines in the treatment of postoperative glycemic 
control have the ability to positively impact patient outcomes (Stuij et al., 2019). Nurses 
play an integral role in the improvement of diabetes management throughout the 
continuum of life (Stuij et al., 2019).  
 Additionally, nurses play an important role in the education of the patient (Jones 
et al., 2018). Data from multiple studies suggest the importance of diabetes specific 
patient education to improve the outcomes and glycemic control of patients living with 





complications and poorer glycemic control (Tan et al., 2019). A nurse with disease 
specific knowledge has the ability to educate a patient living with diabetes on the disease 
(Jones et al., 2018). Per Jiang et al. (2017) psychological evaluation and continued 
support is also required to ensure best outcomes in patients living with diabetes. Nurses 
have a critical role in ensuring psychological well-being and assessments to ensure 
patients are able to care for themselves. To ensure complete evaluation, nurses must also 
assess barriers to care and adequate glycemic control. An individualized, 
multidisciplinary approach is the only method to ensure adequate glycemic control in 
people living with type 2 diabetes (Tan et al., 2019).  
Local Background and Context 
 Rates of diabetes vary throughout the 50 states in the country, and the state of 
Ohio has one of the highest rates of diabetes (CDC, 2017b; Ohio Department of Health, 
2017). Though an estimated 9.4% the United States population has diabetes, the rate in 
Ohio was 12.7% as of 2017 (CDC, 2017b; ADA, 2017). As of 2017, 1,279,000 Ohioans 
are living with diabetes and an estimated 67,000 more individuals are diagnosed yearly 
(ADA, 2017). In the state of Ohio as of 2015, diabetes was listed as the cause of death for 
3,500 individuals and was noted as the 7th leading cause of death (Ohio Department of 
Health, 2017).  
 Along with an increased prevalence of diabetes in Ohio, expenses related to 
diabetes are also elevated. Data published by the ADA (2017) shows that a person living 





compared to individuals living without diabetes. As of 2017, the direct healthcare 
expenditure related to diabetes was $9 billion in Ohio. Additionally, an estimated $3.4 
billion were spent on disability and time away from work related to diabetes in Ohio in 
2017. Overall costs related to a diabetes diagnosis in the state of Ohio in 2017 were $12.4 
billion.     
 The pathophysiology of type 2 diabetes, antihyperglycemic agents, and the co-
morbidity of obesity play a role in bone health and contribute to the need for orthopedic 
surgeries and procedures (Sundararaghavan, Mazur, Evan, Liu, & Ebraheim, 2017). 
Sundaraghavan et al. (2017) wrote patients living with type 2 diabetes have increased 
bone mineral density related to decreased bone turnover and hyperinsulinemia. Decreased 
bone turnover is identified as low type 1 cross-linked C-telopeptide and type 1 cross-
linked N-telopeptde levels. Insulin like growth factor 1 (IGF-1) is a hormone that plays a 
role in bone health and bone mineral density. Hyperinsulinemia is a characteristic of type 
2 diabetes and is thought to act as IGF-1 creating several problems with bone health. One 
known change is the result of the increased osteoblast action resulting in bone changes. A 
second change in bone health is the result of the increased storage and creation of adipose 
tissue noted in the bone marrow stem cell. This is the direct result of a single protein 
cascade that leads to the activation of subsequent proteins and receptors.  
 Obesity and type 2 diabetes are commonly correlated and obesity has been shown 
to effect bone health (Dutta & Ghosh, 2019; Sundararaghavan et al., 2017). Per 





to the increase in adipose tissues and hormones, particularly leptin. Leptin is a hormone 
that decreases the creation of osteoclasts and stimulates the production of osteoblasts. 
Adiponectin is another hormone associated with obesity and lower bone mineral density, 
however, patients with type 2 diabetes have low levels of adiponectin, therefore, higher 
levels of bone mineral density.  
 Several classes of antihyperglycemic agents effect bone health. Sundararaghavan 
et al  (2017) discussed the biguanide class of medications, which includes metformin, has 
been shown to promote bone creation and bone health. The thiazolidinedione (TZD) class 
of medications, which includes rosiglitazone and pioglitazone, was found to cause an 
increase in fracture risk, aside from spinal fractures in women in the ACCORD study. 
The GLP-1 medication class was shown to promote bone health in one study and 
compromise bone health in another. The Dipeptidyl peptidase-4 (DPP-4) medication class 
has a neutral effect on bone health. Sodium–glucose co-transporter 2 (SGLT2) inhibitors 
work in the kidney causing a rise in phosphate and therefore elevated parathyroid 
hormone levels resulting in increased bone resorption and poor bone outcomes. Lastly, 
the sulfonylurea medication class may improve bone health or have neutral effects.  
 Overall, Sundararaghavan et al. (2017) found that patients living with diabetes 
have an increased fracture risk related to medication use, disease pathophysiology, co-
morbidities, or other factors. Though patients living with type 2 diabetes have increased 
bone mineral density in some trabecular bone, bone mineral density is weaker in 





risk. Obesity and elevations in BMI may account for further negative bone change related 
to immobility, risk of accident or injury, and the potential for hormonal irregularities 
including testosterone levels. Studies have also shown a positive correlation between 
complications of diabetes including retinopathy, nephropathy, and neuropathy and risks 
of fractures, especially in the hip.  
 With the knowledge of the increased risk of bone fractures in patients living with 
type 2 diabetes, it is also important to consider the potential complications of poor health. 
Per Sundararaghavan et al (2017), patients living with type 2 diabetes have slower bone 
healing related to dysfunctions in production of growth hormones, collagen, failed 
cartilage transfer, and defective protein synthesis. In addition to poor bone health and 
poor bone healing, changes in the joint related to excess glucose and poor diabetes 
control, raises the risk of the need for surgical intervention for fracture or joint problems. 
Aside from poor bone and surgical healing, a primary concern is risk of infection. 
Researchers have found that patients living with type 2 diabetes are two to four times 
more likely to develop a postoperative infection when compared to individuals without a 
type 2 diabetes diagnosis.    
 Poor bone health, increased fracture risk, and increased likelihood of the need for 
surgical intervention to eliminate joint problems, adds to the difficulties of living life with 
type 2 diabetes (Sundararaghavan et al., 2017). Injuries to the bone and surgical 
interventions, especially when complicated by infections, lead to prolonged periods of 





psychological impacts including decreased perceptions of quality of life (Garg et al., 
2016). Nursing professionals are charged with caring for and ensuring the best outcomes 
for patients (Jiang et al., 2017). When the patient is hospitalized following an orthopedic 
procedure, the nurse must address the mental, physical, and medical needs of the patient 
to return the patient to their previous health level (Jiang et al., 2017).  
Role of the DNP Student 
 Completion of the DNP project requires complete emersion on behalf of the DNP 
student. To begin the project, identification of a healthcare problem that has a great 
societal impact is necessary. To determine the project focus, consideration to global, 
national, and local health is imperative. On the local level, type 2 diabetes has a high 
prevalence (Ohio Department of Health, 2017). With the recent addition of a healthcare 
system based orthopedic group, an increase in patients living with type 2 diabetes 
receiving orthopedic procedures and surgeries has been noted. Research showed the 
potential for poor outcomes in patients living with type 2 diabetes following surgical 
intervention within the acute care or hospital setting (Sundararaghavan et al., 2017). 
Therefore, the focus of the project surrounds guideline development to assist with the 
glycemic control of patients living with type 2 diabetes following orthopedic intervention 
requiring hospitalization. 
 The DNP project is meant to elicit exemplary nursing practice and scholarship 
(Root, Nunez, Velasquez, Malloch, & Porter-O’Grady, 2018). Projects should be 





knowledge and assimilation of evidence to practice, which may lead to healthcare 
improvements (Root et al., 2018). The American Association of Colleges of Nurses 
(AACN, 2006) wrote of the standards for the DNP educated nurses. To complete this 
project, DNP essentials I, II, III, and VI were used (AACN, 2006). The essentials require 
the utilization of science and evidence, system changes and improvements, scholarship 
and evidence-based practice utilization, and the multidisciplinary approach to improve 
population health problems (AACN, 2006).  
Through research, the importance of the nurse’s role in glycemic control is noted 
(Jiang et al., 2017). Nurses play an integral role in the education and provision of self-
management and coping skills for the patient, as well as direct psychological and physical 
healthcare needs (Jiang et al., 2017). With the understanding of the great impact nurses 
have on glycemic control as well as the published guidelines citing the guidelines and 
recommendations for euglycemia postoperatively, the development of a clinical practice 
guideline focusing on the nurse’s role in the improvement of postoperative glycemic 
control is found to be necessary (Jiang et al., 2017; ADA, 2019b). My role in the 
development of the clinical practice guideline began with the identification of a problem 
and continued through literature search and review to determine a potential change 
implementation that would elicit positive social change and patient outcomes. Motivation 
for project completion included a family and personal history of diabetes and continued 





avoid this bias, I based recommendations on high quality research articles and guidelines 
retrieved through a thorough search and analysis of the literature.  
Role of the Project Team 
 I worked with several members of the University faculty, as well as mentors to 
successfully complete the DNP project. Walden University provided me with a project 
committee, which included a committee chair, committee member, and university 
research reviewer (Walden University, 2018). Additionally, the chief academic officer 
will play a role in the final approval of the project (Walden University, 2018). This 
review process ensures project rigor and focus on the goals of societal change and 
population health improvement (Root et al., 2018). The Appraisal of Guidelines for 
Researching & Evaluation (AGREE) II instrument was used by experts in the field to 
evaluate the appropriateness of the developed guideline. Following the project timeline 
and approval process, the team members had several opportunities to review the material 
and data supporting the clinical practice guideline (Walden University, 2018).  
 Because the multidisciplinary team approach is crucial to successful diabetes 
management, a team within the clinical location assisted in the creation of the final 
clinical practice guideline. I collaborated with the local endocrinologist, diabetes 
educators, nurses on the orthopedic unit, and members of the orthopedic team. This team 
approach allowed for collaborative and functional production of a clinical practice 
guideline that may be easily assimilated into practice. I ensured that the project 





personal accounts and feedback to help guide the clinical practice guideline. Team 
members were updated with each submission of the project to Walden University to 
ensure the entire team was aware of the project status.  
Summary 
 As the prevalence of type 2 diabetes increases, the social and healthcare impacts 
of poor control create a greater strain on society and the healthcare system (Maa, 2017). 
Identification of a specific problem, poor glycemic control following an orthopedic 
procedure requiring hospitalization, allowed for a focused analysis and potential 
resolution through developing a clinical practice guideline. To create an effective clinical 
practice guideline, reputable research must be used. Additionally, a team approach may 
ensure rigorous publication and a sound clinical practice guideline to ensure a powerful 





Section 3: Collection and Analysis of Evidence 
Introduction 
Type 2 diabetes is a chronic health condition with complications that may 
devastate the individual diagnosed with the disease (Hurtado & Vella, 2019). The high 
prevalence rate and poor control seen in the United States result in a negative effect on 
society overall (CDC, 2017b). Of special concern are postoperative wound healing 
(Underwood et al., 2014). The risks of poor glycemic control include evisceration, poor 
wound healing, infection, surgical failures, delay in return to normal functional ability, 
and mortality (Yong et al., 2018). Specifically, orthopedic procedures that require 
inpatient stays create a challenge for nurses and care providers who are attempting to 
reach optimal glycemic control for the patient living with type 2 diabetes postoperatively 
(Underwood et al., 2014).  
The project will enhance nursing practice through the development of a practice 
guideline. The guideline, a synthesized version of current research and recommendations, 
may improve glycemic control in hospitalized patients following an orthopedic 
procedure. The guideline will allow nurses to educate patients, advocate for patients, and 
assist patients with self-management and self-efficacy to improve glycemic control 
(Akiboye & Rayman, 2017).  Because living with type 2 diabetes requires a great deal of 
self-management, it is imperative that even within the hospital setting, nurses are 
ensuring the patients have an understanding of their role in the management of the 





management, nurses and healthcare providers need to follow a standardized guideline that 
helps with glycemic control to prevent life-limiting or life-altering postoperative 
complications and ensure optimal patient outcomes (Akiboye & Rayman, 2017).  
Locally, in the state of Ohio, the prevalence rate of diabetes was 12.7% as of 
2017, compared to a national prevalence rate of 9.4%, which means that more people in 
Ohio are living with a diabetes diagnosis and that it is considerably more likely that they 
would require intensive glycemic management during a hospitalization than elsewhere 
(CDC, 2017b, Ohio Department of Health, 2017). It is estimated that in Ohio alone, $9 
billion is spent annually on direct diabetes healthcare costs and $3.4 billion is spent on 
indirect costs associated with a diabetes diagnosis (ADA, 2017). In relation to orthopedic 
surgeries, researchers have also found correlations between some antihyperglycemic 
agents and poor bone health, thus increasing the potential need for a fracture repair 
surgery (Sundararaghavan et al., 2017). On the local level, a newly established orthopedic 
practice and unit within a healthcare system,  along with limited access to endocrinology 
services and diabetes education, have complicated the way in which optimal 
postoperative glycemic control is achieved.  
 To further solidify the importance of this problem, I will restate the practice-
focused question and relate the question to the DNP project goals. The research 
supporting the development and appropriateness of a clinical practice guideline will be 
discussed and analyzed. The location of the research and guidelines as well as a 





research will be stated. The project did not include any local or organizational data and I 
did not conduct any research studies individually. A summary of the approach will be 
detailed and reviewed in-depth. 
Practice Focused Question  
The project aim is to enhance nursing practice through creation of a clinical 
practice guideline to assist with the improved management of glycemic control following 
an orthopedic procedure requiring an inpatient stay in the person living with type 2 
diabetes. The practice-focused question was developed using the PICO format as follows: 
What are the evidence-based practice recommendations for adults aged 18 years and 
older living with type 2 diabetes, for glycemic management following an orthopedic 
procedure requiring hospitalization?  To answer this question, a thorough review of the 
research and evidence was required. A thorough analysis of the recommendations and 
outcomes allowed for further exploration of the impact a clinical practice guideline 
standardizing postoperative glycemic control and education following an orthopedic 
procedure would have on the improvement of glycemic control postoperatively. The 
operational definitions used for completion of this DNP project were as follows: 
Clinical practice guideline: A written work formulated through a research review 
and analysis process that results in an evidence-based set of patient-focused 
recommendations that may improve quality of care and patient outcomes 





Glycemic control: Within the hospital setting, glycemic targets of 100-180 or 100-
140 if achievable without hypoglycemia equate to glycemic control (ADA, 
2019b).  
Postoperative: The period of time following a surgical or operative procedure 
(Mick & Guastella, 2013).  
Sources of Evidence 
Published recommendations and outcomes were used as sources of evidence to 
ensure the practice-focused question was answered as required for this project. The 
sources of evidence were in the form of peer reviewed journal articles, published 
organizational guidelines and recommendations, books, and organizational and public 
websites. The goal of this project was to enhance glycemic control following an 
orthopedic procedure for hospitalized patients. The developed clinical practice guideline 
will assist nurses as they advocate and care for these patients. To develop a thorough and 
evidence-based clinical practice guideline, a literature review and synthesis was 
required. A literature review is defined as an intense review and analysis of high-quality 
evidence and research that allows for synthesis of appropriate guidelines (Burgers, 
Brugman, & Boeynems, 2019).  
To ensure the practice-focused question was addressed, a comprehensive and 
thorough literature review was completed. The literature review included synthesis and 
analysis of type 2 diabetes management techniques, research, and published guidelines 





organizations, scholars and experts in the field, and high-quality research findings.  The 
following databases were used to conduct the literature review: CINAHL, PubMed, 
Medline, Cochrane, and SAGE. The following search terms were used: type 2 diabetes, 
postoperative, orthopedic surgery, glycemic control, self-management, self-efficacy, 
guidelines, standards, education, nursing, hospitalization, inpatient, and glucose. The 
literature review included publications dated 2006 to 2020.  
Several reputable organizations offer guidelines, recommendations, and research 
in diabetes management. The ADA (2019b) issues a yearly guideline that implicitly 
states recommendations for glycemic control for hospitalized patients. The ADA 
(2019b) also supports self-management education and the multidisciplinary team 
approach to improve glycemic control. The American Association of Diabetes Educators 
(AADE, 2019) supports diabetes self-management education and emphasizes the 
importance of glycemic control through the continuum of care. Additionally, AACE 
(2019a), and the Endocrine Society (Umpierrez et al., 2012) offer guidelines for the 
management of type 2 diabetes through the life span and both note the importance of the 
multidisciplinary team as well as education that improves self-efficacy. Lastly, as noted 
in the DAWN study, attention to the patients’ perceived quality of life and the patients’ 
ability to self-manage their type 2 diabetes is of the utmost importance (Funnell, 2006).  
 The aforementioned literature review, key terms, databases, and publication 
years allowed a thorough analysis and synthesis of the current literature. Collection of 





based clinical practice guideline that will be used to optimize patient outcomes. As the 
goal of the project was to improve postoperative glycemic control, specifically in 
patients requiring an inpatient stay following an orthopedic surgery, it was important to 
evaluate glycemic control during hospitalization and glycemic control following other 
surgical procedures. This robust literature review of the highest quality evidence allowed 
me to produce a high-quality clinical practice guideline. 
Analysis and Synthesis 
A clinical practice guideline is a written work formulated through a research 
review and analysis process that results in an evidence-based set of patient-focused 
recommendations that may improve quality of care and patient outcomes (AAFP, 2019). 
Clinical practice guidelines should be composed of the highest quality, evidence-based 
research that has the positive potential to influence patient outcomes and elicit social 
change (AAFP, 2019). As a clinical practice guideline should include high quality 
research, it is important for the developer of the clinical practice guideline as well as the 
reader to understand the level and quality of evidence. A literature review includes the 
formal analysis of research quality and commonly, levels of evidence are used (Johns 
Hopkins Medicine, 2019).  
The Oxford Centre for Evidence-Based Medicine Levels of Evidence (2011) 
literature assessment offers an effective way to categorize research by quality. The levels 
of evidence presented offer levels 1 through 5 based on the aim of the study, the study 





to a letter A through D with the highest quality research earning a level A grade (Oxford 
Centre, 2011). For example, research aimed at prevention conducted using an individual 
cohort study would receive a level 2b grade (Oxford Centre, 2011). An initial grade of 2b 
translates to a letter B grade (Oxford Centre, 2011). The guideline is complex and 
specific allowing for appropriate categorization of the research and the extrapolation of 
high-quality research (Oxford Centre, 2011). To keep the literature organized and the 
grading criteria easily accessible, a literature matrix was used (See Appendix A).   
The AGREE II instrument, an in-depth tool to assist with the development of 
clinical practice guidelines, was applied to ensure the quality of the clinical practice 
guideline (Brouwers et al., 2010). The tool required utilization of 23 criteria levels and 
six areas of appraisal (Brouwers et al., 2010). The six domains include: (a scope, (b) 
stakeholder involvement, (c) rigor, (d) clarity, (e) applicability, and (f) editorial 
independence (Brouwers et al., 2010). Scores were based on completeness, quality, 
rigor, and overall cohesiveness and evidence-based research level of support for the 
clinical practice guideline (Brouwers et al., 2010).  
This tool was used by the project team members and experts in the field. As a 
Walden University (2019) requirement, the AGREE II tool is used to analyze and 
approve final scholarly projects. Initially, the AGREE II criteria act as a guide for 
clinical practice guideline development. I self-evaluated the rough draft of the final 
project using the AGREE II checklist. After initial revisions, the AGREE II instrument 





nurses, a diabetes educator, a registered nurse working on the orthopedic unit, an 
orthopedic surgeon, and three registered nurses working in the endocrinology office. The 
expert panel evaluated and graded the clinical practice guideline. When the second 
revision, based on expert panel feedback was complete, the same group of experts 
provided with the final revision and the instrument again graded the guideline. The 
development of the clinical practice guideline was considered complete when a high 
score was achieved and no further revisions were necessary. 
Institutional Review Board (IRB) approval was obtained (approval #02-25-20-
0516844) to ensure the ethical requirements of the project were met. This approval 
required the completion of a document and acceptance of that document by the IRB 
following the completion of the project proposal oral defense. The ethical requirements 
for the project included institutional privacy, patient privacy, assurance of no data 
collection, and assurance that all partner organization or institution rules and regulations 
were upheld. With all matters concerning patient outcome and patients in general, 
confidentiality is of the utmost importance and must be considered a top priority (Oye, 
Dahl, Sorensen, & Glasdan, 209). This project did not collect or use patient data nor 
entail patient participation.     
Additionally, the AACN (2006) DNP Essentials were used to help guide the 
scholarly project, the clinical practice guideline development, and the in-depth analysis 
and review of the current research and literature. The Essentials guide the scholarly 





(AACN, 2006). My adherence to the essentials was evidenced by the creation and 
synthesis of a clinical practice guideline that was thoroughly assessed for quality and 
rigor. Additionally, the clinical practice guideline addressed several of the DNP 
Essentials including the importance of the doctorally prepared nurse to act as an integral 
member of the healthcare team, enhance the profession of nursing, and exhibit nurses’ 
role in social change (AACN, 2006).  
Summary 
Type 2 diabetes is a problem of epidemic proportion that negatively affects the 
physical and mental health of millions of Americans (CDC, 2017b). Specifically, 
uncontrolled type 2 diabetes following an orthopedic surgery that requires hospitalization 
contributes to negative outcomes for patients and places a financial and resource burden 
on the healthcare system (Underwood et al., 2014). To improve patient outcomes, 
research, current guidelines, and organizational data may be synthesized into a clinical 
practice guideline that may inform nurses as they assist with advocacy and education to 
improve patient outcomes (AAFP, 2019). To ensure rigor and quality of the clinical 
practice guideline, it is vital to ensure the literature and the clinical practice guidelines are 
based on high quality research that show positive health benefits and patient outcomes 
(Brouwers et al., 2010). A complete analysis and synthesis of the literature along with 







Section 4: Findings and Recommendations 
Introduction 
 Type 2 diabetes is a problem of epidemic proportion that continues to grow 
(CDC, 2017b). In America, 30.3 million people were living with a diabetes diagnosis as 
of 2015 (ADA, 2019a). Type 2 diabetes is a chronic, progressive disease that may lead to 
a number of microvascular, macrovascular, and psychological complications (Hurtado & 
Vella, 2019). Diabetes-related distress has been associated with poor perceived quality of 
life and increased rates of depression (Garg et al., 2016). The treatment algorithm for the 
management of hyperglycemia requires lifestyle modifications, behavior change, and 
commonly, multiple medications (ADA, 2019b).  
Additionally, for people living with diabetes who require an orthopedic 
procedure, hyperglycemia has many negative postoperative outcomes: evisceration, poor 
wound healing, increased infection rate, prolonged hospital stay, delayed return to normal 
activities, and mortality (Yong et al., 2018). Locally, in Ohio, the incidence rate of 
diabetes is 12.7%, which is higher than the national population incidence rate of 9.4% 
(CDC, 2017b; ADA, 2017). Poor glycemic control in general and postoperatively places 
a financial and resource burden on the healthcare system and contributes to negative 
societal effects noted by the financial healthcare burden (Maa, 2017).  
Based on an understanding of the negative outcomes associated with type 2 
diabetes, a practice-focused question was developed for this project: What are the 





with type 2 diabetes, for glycemic management following an orthopedic procedure that 
required hospitalization?  Clinical practice guidelines are developed to improve clinical 
outcomes (AAFP, 2019). Several organizations have created clinical practice guidelines 
addressing glycemic control postoperatively and during hospitalization (ADA, 2019b; 
AACE, 2019a; Umppierrez et al., 2012). The purpose of this DNP project was to improve 
patient outcomes by synthesizing the current guidelines and recommendations into a 
concise practice guideline that addresses postoperative glycemic control following an 
orthopedic procedure requiring hospitalization.  
To create the clinical practice guideline, many sources of evidence were 
reviewed. The following databases were used to obtain articles published between 2006 
and 2020: CINAHL, PubMed, Medline, Cochrane, and SAGE. The following keywords 
were used: type 2 diabetes, postoperative, orthopedic surgery, glycemic control, self-
management, self-efficacy, guidelines, standards, education, nursing, hospitalization, 
inpatient, and glucose. The literature was reviewed and analyzed according to the 
Oxford Centre for Evidence-based Medicine scale, Levels of Evidence to ensure high-
quality evidence. Additionally, the AGREE II tool was applied to the draft guideline by 
experts in the field of diabetes management. The purpose of this section is to discuss the 
findings, implications, and recommendations; the contribution of the DNP project team; 







Findings and Implications 
 Multiple literary works were reviewed and critically analyzed for this project. The 
literature reviewed focused on several aspects of living with type 2 diabetes and type 2 
diabetes management in general, as well as specifically pertaining to surgical operations. 
The literature review explored the effect of self-efficacy and self-management education 
on glycemic control (Azami et al., 2018; Jamiszewski, O’Brian, & Lipman, 2015). 
Funnell (2006) explored the psychological effect of living with diabetes. Lee et al., 
(2016) discussed the impact and negative outcomes associated with hyperglycemia 
postoperatively . Additionally, the professional guidelines as stated by the ADA (2019a), 
Endocrine Society (Umpierrez et al., 2012), and AACE (2019) were analyzed. The 
literature review was inclusive and thorough with the aim of building a practice 
guideline. 
 Akiboye and Rayman (2017) explored the current guidelines and 
recommendations for preoperative glycemic control and evaluated the effectiveness of 
current care. The researchers determined preoperative glycemic control as well as 
perioperative control has an impact on surgical outcomes (Akiboye & Rayman, 2017). To 
determine the specific impact of postoperative outcomes, more research and data 
collection would be required. However, the research findings are valuable and the 
evidence is strong.  
 Lee et al. (2016) completed a retrospective analysis of hyperglycemia 





postoperatively were established. The researchers reviewed 60 historical charts from the 
point of the operation through several months postoperatively. Though the researchers 
concluded the negative and prolonged effects of hyperglycemia persist for several months 
postoperatively, a larger participant group would be beneficial to provide more direction 
on how to prevent prolonged hyperglycemia postoperatively.  
 Several other studies suggested correlations of diabetes to poor surgical outcomes 
as well. Underwood et al. (2014) found postoperative complications were significantly 
higher in patients living with diabetes with an A1C of 8% or greater. Asida et al. (2013) 
also found more negative postoperative outcomes with poor glycemic control 
specifically. Penrose and Lee (2013) found that postoperative outcomes were directly 
correlated to preoperative glycemic control. The researchers recommended an intense 
analysis of preoperative glycemic control to decrease negative postoperative outcomes 
(Penorse & Lee, 2013). These combined findings suggest the need to assess preoperative, 
intraoperative, and postoperative glycemic control is important to ensure positive surgical 
outcomes.  
 Azami et al. (2018) published a study that included 142 participants to determine 
if nurse-led diabetes intervention groups would lead to improvements in diabetes control. 
The participants were divided into two groups and one group received the intervention, 
while the other group did not. The nurse-led intervention included self-management 
education, a survey of self-efficacy, and individualized care with frequent follow-up. The 





improvement in A1C, self-efficacy, and self-management skill. Though the outcomes 
were positive, the study should be explored on a larger scale with a longer follow-up 
window to ensure accuracy of the study findings. 
 The effect of care management and self-management education on glycemic 
control was explored by Janiszewski et al., 2015. Again, self-education and self-
management skill were positively associated with improved glycemic control and self-
efficacy. The study did have some flaws, which included a limited participant size and 
short follow-up time. While self-management is important, the technique of education 
delivery is also important according to the research of Van Smoorenburg, Hertrojis, 
Eliseen, and Melles (2019). The authors cited value in self-management education and 
ability for glycemic control, however, they emphasized the need for less structured and 
more individual education and care delivery.  
 Davis et al. (2019) cited the importance of nurse-led programs and shared medical 
appointments, which led to empowerment in patients living with type 2 diabetes and also 
contributed to increased self-management, self-efficacy, and glycemic control. Garg et al. 
(2016) found that patients receiving diabetes care and management services from nurse 
practitioners were more likely to reach glycemic targets. The researchers found 87% of 
study participants receiving intervention in the form of diabetes management from nurse 
practitioners met their glycemic targets. Research published by Stuij et al. (2019) 





cultivated out of a traditional clinic space. However, this research had few participants 
and scored low on the evidence scaling (Stuji et al., 2019).  
 Psychological distress has also been identified as an area that should be assessed 
when considering glycemic control (Armani Kian et al., 2018). The original DAWN 
study included a large group of participants (Funnell, 2006). The researchers were able to 
ascertain the connection between a diabetes diagnosis and disease distress (Funnell, 
2006). Joensen et al. (2017) discussed the aforementioned DAWN 2 study. The 
researchers determined that patients living with diabetes faced a great deal of disease 
distress (). Not only were the patients living with diabetes afflicted with disease distress, 
caregivers and loved ones also felt disease burden and distress. Additional research 
conducted by Armani Kian et al. (2018) showed patients had improved glycemic control 
and perceptions of self when they were taught stress management skills and provided 
with emotional support.  
 Additionally, professional guidelines were reviewed to comprehensively assess 
the current practice standards for postoperative glycemic management. The ADA (2019b) 
Standards of Care offered guidance on management of diabetes during hospitalization 
and in the special circumstance of surgery. These guidelines were created after thorough 
conduct of research and exploration of findings by many experts in the field of diabetes 
management. The recommendations within the Standards of Care are analyzed based on 
strength of research. Additionally, the guidelines are updated yearly and more frequently 





 The ADA (2019b) offered an array of recommendations for glycemic 
management. The recommendations include medication and lifestyle interventions as 
well as self-management education. Specifically, the ADA recommends informal 
diabetes education to teach self-management skills. Additionally, the ADA offers 
guidelines on target glycemic control for patients during hospitalization and calls for 
moderate intensity control to prevent both hypoglycemia and hyperglycemia and improve 
patient outcomes.  
 The joint guideline of the ACE and AACE (2019) offers evidence-based 
recommendations for the management of glycemic control. The organizations joined 
together to create a treatment algorithm for type 2 diabetes in general. Additionally, a 
second algorithm offered instruction on the intensification of insulin regimens. This is of 
particular importance as insulin is the recommended treatment option for patients during 
times of hospitalization (ADA, 2019b). The guidelines are strong and backed by two 
nationally-recognized organizations depicting evidence-based findings and expert 
opinion (AACE, 2019).  
 Lastly, Umpierrez et al. (2012) detailed the recommendations of the Endocrine 
Society, another highly recognized organization. The Endocrine Society guideline depicts 
the need for preoperative glycemic control. The guideline also recommends intense 
management of glycemic control postoperatively to improve patient outcomes. The 
guideline coincides with the guidelines and recommendations of the ADA, ACE, and 





 The research and professional organization guidelines offered recommendations 
on the need for and way to achieve glycemic postoperatively. The research suggested the 
need for preoperative glycemic management to achieve postoperative glycemic control 
(Underwood et al., 2014). Additionally, the research was clear that insulin should be used 
as the treatment modality during hospitalization (ADA, 2019b). The guidelines also 
recognized the importance of eliminating hypoglycemia during hospitalization to prevent 
negative patient outcomes (ADA, 2019b). The guidelines and recommendations also 
stated the importance of the healthcare providers’ knowledge of diabetes and diabetes 
management to achieve optimal glycemic goals and the need for the interdisciplinary 
team (Reategui et al., 2015). The complete recommendations from the literature review 
have been compiled into a clinical practice guideline (see Appendix B).  
 Several of the research studies did have some limitations. The work of Garg et al. 
(2016) was rated as a Level 3b when applying the Oxford Centre for Evidence-Based 
Levels of Medicine grading system. The publication of Sunj et al. (2019) scored a level 5 
on the same grading system. These lower level research findings indicated lack of 
strength in the study and findings. One of the studies also had a limited sample size, 
which may discredit the findings (Lee et al., 2016). An additional limitation to the 
literature review process itself was the lack of orthopedic surgery specific research.  
 Overall, the research findings have implications for patients living with diabetes, 
healthcare providers, healthcare organizations, and society. From a patient perspective, 





healthcare organizations may result in improved glycemic control and improved 
postoperative outcomes. Improved glycemic outcomes may results in a variety of 
improved patient outcomes including improved physical and mental health (Guo et al., 
2016). The findings also allow for healthcare providers to gain knowledge on the 
treatment approaches that may improve glycemic control and patient outcomes. 
Knowledgeable healthcare providers have a greater ability to improve patient outcomes 
(Reategui et al., 2015).  
 Healthcare organizations on both a small and large scale could benefit from the 
findings and recommendations to improve postoperative glycemic control. Healthcare 
organizations are often graded on postoperative outcomes as well as hospital readmission 
rates, both of which may be improved with better glycemic control following an 
orthopedic surgery (Grover & Joshi, 2014). Additionally, glycemic control in the hospital 
is imperative to keep patients safe as the risks of hypoglycemia during the hospitalization 
continue after hospital discharge (ADA, 2019b). From a societal standpoint, due to the 
great number of Americans living with diabetes and the potential ill consequences of 
uncontrolled diabetes and postoperative outcomes associated with poor diabetes control, 
the societal implications of glycemic control are great (Maa, 2017). Patients living with 
type 2 diabetes have a greater ability to function within society and contribute adequately 
if they achieve glycemic control (Maa, 2017). If patients living with diabetes are cared 
for on both a physical and mental level, the rates of depression and distress may be 






 The clinical practice guideline created for this project can be used by nurses to 
assist with postoperative glycemic control, specifically in patients living with type 2 
diabetes following an orthopedic surgery requiring hospitalization. The purpose of a 
clinical practice guideline is to improve quality of care and care outcomes (Roof et al., 
2018). Improving glycemic control and decreasing the negative outcomes and 
complications associated with diabetes postoperatively allow for improvements in care 
and quality (ADA, 2019b). Additionally, a clinical practice guideline affords all 
healthcare professionals the ability to gain knowledge and have a resource to guide the 
care of patients with complex conditions.  
 In order to create the clinical practice guideline, many steps needed to occur. 
Initially, a problem was identified. The problem was selected based on my professional 
experience and notation of a problem in achieving glycemic control postoperatively, 
specifically following orthopedic procedures. A thorough research review was required to 
(a) identify the effects of poor glycemic control postoperatively, and (b) determine 
evidence-based research and guidelines to assist with improved glycemic control 
postoperatively. The evidence then required reviewing, grading, and synthesis for 
translation into a clinical practice guideline. 
 The clinical practice guideline was created to (a)  provide concise, evidence-
based, and easily implementable information, (b) focus on improvement of the negative 





importance of preoperative glycemic control for postoperative glycemic control, (d) 
ensure self-management and self-efficacy are addressed during the care of the patient 
with type 2 diabetes, and (e) ensure appropriate and adequate assessment and 
management of patients’ psychological distress. Although several guidelines existed to 
assist with glycemic management postoperatively, the guidelines were often lengthy and 
difficult to follow. The creation of one inclusive clinical practice guideline that could be 
used by those with and without prescriptive authority supports easy implementation and 
more diverse utilization.  
 Additionally, sharing the literature depicting the poor outcomes associated with 
impaired glycemic control postoperatively within the clinical practice guideline allowed 
for an easier understanding of the gravity of the problem. The research reviewed also 
substantially highlights the importance of preoperative glycemic control in order to 
achieve improved postoperative glycemic control and outcomes (ADA, 2019b). Although 
the aim of the clinical practice guideline development was specifically to improve 
postoperative glycemic control, preoperative glycemic control must be achieved to 
achieve postoperative glycemic control (ADA, 2019b). 
 The guideline also addressed self-management and self-efficacy as these are two 
important contributors to glycemic control (Van Smoorenburg et al., 2019). As diabetes 
is mainly self-managed, it is important to assess the patient’s knowledge base, ability to 
self-manage, and self-efficacy behaviors (Van Smoorenburg et al., 2019). If the education 





advocacy is necessary to improve the patient’s ability to manage diabetes successfully 
(Van Smoorenburg et al., 2019). Likewise, distress and depression are two common 
conditions seen in individuals living with diabetes (Armani Kian et al., 2008; Egede et 
al., 2016). Both distress and depression can prevent patients from achieving glycemic 
control (Armani Kian et al., 2008; Egede et al., 2016). The guideline addresses the need 
to screen patients for both diabetes distress and depression on a routine basis to ensure 
patients are psychologically capable of participating in disease management. 
 To fulfill the purpose of clinical practice guideline development, several sections 
of information, education, and recommendations were created (see Appendix B). The 
first section of the clinical practice guideline discusses preoperative glycemic control. 
Preoperative glycemic control is discussed in terms of (a) general diabetes management 
goals, (b) lifestyle modifications, (c) medications, (d) diabetes education, self-
management, and self-efficacy, (e) psychological implications, and (f) the nurses’ role. 
The second section of the clinical practice guideline depicts the necessary education and 
recommendations to achieve intraoperative glycemic control. The third and final section 
offers education and recommendations for postoperative glycemic control during a 
hospitalization. Recommendations throughout the clinical practice guideline were based 
on existing clinical practice guidelines, professional organization recommendations, and 
evidence-based research. The recommendations were graded using the Oxford Centre for 





 Preoperative glycemic control begins with a healthcare providers’ general 
knowledge base of diabetes and expected glycemic control goals. Organizations 
including the ADA (2019b) and AACE (2019) offered recommendations for general 
diabetes control in the form of an A1C result. Preoperatively, it was recommended that 
the A1C value be as close to goal as possible and should not exceed an 8% (Underwood 
et al., 2014). The A1C goal is achievable through lifestyle modification, education, 
medication, and consideration of psychological factors (ADA, 2019b).  
 In terms of lifestyle modification, the ADA (2019b) recommended improved 
nutrition, increased physical activity, improved sleep habits, and decreased alcohol and 
tobacco intake to improve glycemic control. Pharmacologic management of 
hyperglycemia can be achieved using the joint ACE/AACE (2019) medication algorithm 
and insulin intensification guidelines. The algorithm and intensification guide are shared 
in their entirety in the clinical practice guideline. Although lifestyle changes and 
pharmacologic management of diabetes are crucial, continued management efforts will 
likely fail if the patient is not educated on self-management techniques and does not have 
a level of self-efficacy (Van Smoorenburg et al., 2019). Because of this, a portion of the 
guideline is dedicated to the current recommendations for diabetes self-management 
education. The current recommendations seek to ensure clinicians are educated on the 
usefulness of diabetes education, the availability of the program, and methods to evaluate 
patients for the need for additional self-management and disease education (AADE, 





 The initial section of the guideline discusses the need to evaluate the 
psychological impact of type 2 diabetes. As previously established, rates of diabetes 
distress are high in individuals living with diabetes (Funnell, 2006; Joensen et al., 2017). 
Diabetes distress can contribute to poor self-management skill and noncompliance 
(Armani Kian et al., 2008). Higher rates of depression are also seen in individuals living 
with diabetes (Egede et al., 2016). Depression has negative implications for glycemic 
control and health in general (Egede et al., 2016). The clinical practice guideline seeks to 
reiterate the high rates of distress and depression, the negative consequences of these 
psychological ailments, the importance of screening for these disorders on a routine basis, 
and the need for specialized care for distress and depression.  
 The nurse plays an integral role in assisting with the management of glycemic 
control (Stuij et al., 2019). The clinical practice guideline addressed the importance of the 
nurses’ role and the ability of the nurse to advocate for, educate, and care for patients 
living with diabetes (Stuij et al., 2019). The role of the nurse should not be understated in 
terms of postoperative glycemic management. Lastly, the guideline depicts general 
recommendations preoperatively, which include cessation of certain antihyperglycemic 
control, continued glycemic control, and assessment of any metabolic abnormalities 
related to diabetes prior to the surgical procedure.  
 The second section of the clinical practice guideline discussed the 
recommendations for glycemic control intraoperatively. The ADA (2019b) recommends 





phase. Blood sugars should be kept between 100 and 180 during the surgical procedure. 
Treatment of both hypoglycemia and hyperglycemia should be initiated if blood sugars 
fall outside of the parameters using the ADA guidelines for the management of diabetes 
during hospitalization.  
 The third and final section of the clinical practice guideline discusses true 
postoperative glycemic control during a hospitalization, specifically targeting patients 
following an orthopedic surgery. Because conditions of the joints are negatively affected 
by high levels of sugar, it is imperative to continue to maintain adequate glycemic control 
during hospitalization postoperatively. High level recommendations include treatment of 
hyperglycemia with basal insulin as well as sliding scale or prandial insulin plus sliding 
scale insulin. Insulin therapy should be initiated with glucose levels greater than 180. 
Hypoglycemia protocols should be followed per facility protocol and basal insulin dosage 
should be decreased with hypoglycemia to prevent the recurrence of hypoglycemia. It is 
of the utmost importance to formulate a discharge plan that allows for glycemic control 
sustainability.  
  These recommendations are discussed in the clinical practice guideline as 
published in Appendix B. The clinical practice guideline was thoroughly analyzed for 
appropriateness using the AGREE II tool. The AGREE II tool is used to ensure quality 
clinical practice guideline development and implementation (Brouwers et al., 2010). The 
AGREE II tool requires the completion of a 23 section appraisal reviewing six important 





domains focused on: (a) scope, (b) stakeholder involvement, (c) consistency, (d) clarity, 
(e) applicability, and (f) editorial independence (Brouwers et al., 2010). Evaluators may 
rank each section with a score of one to seven with a seven being the highest obtainable 
score. For the purpose of this project and clinical practice guideline development, the 
AGREE II tool was used to assess the clinical practice guideline by two 
endocrinologists, a diabetes educator, a registered nurse working on the orthopedic unit, 
an orthopedic surgeon, and three registered nurses working in the endocrinology office. 


















Table 1.  
AGREE II Overall Guideline Assessment Question   
  
AGREE II Team Member Overall Guideline Assessment  
Question 1. Rate the overall quality of this 
guideline  
  
     
  Rate Total Score 
Appraiser 1  7 7 100% 
Appraiser 2  7 7 100% 
Appraiser 3  7 7 100% 
Appraiser 4  7 7 100% 
Appraiser 5  7 7 100% 
Appraiser 6  7 7 100% 
Appraiser 7  7 7 100% 
Appraiser 8  7 7 100% 
 Total 56 56 100% 
Note. AGREE II scoring ranges from 1 (lowest possible quality) through 7 (highest possible quality) 
With 8 appraisers, the maximum total score possible is 56 and the minimum total score possible is 8.  
The total score percentage was obtained by adding all individual scores and dividing by the total possible 
points. 56/56=1; 1 x 100 = 100%  
 
Contributions of the Doctoral Project Team 
 The doctoral project team consisted of two endocrinologists, a diabetes educator, 
a registered nurse working on the orthopedic unit, an orthopedic surgeon, and three 
registered nurses working in the endocrinology office. The interdisciplinary team 
membership allowed for an enormous amount of knowledge from a nursing, diabetes 





project team was purposely selected to ensure all areas of expertise were given an 
opportunity to contribute their specialized knowledge. Members of the team assisted 
with the project by offering expert opinion, personal experience, and advice on reputable 
organizations and sources of evidence. This information and expert opinion was helpful 
for the data collection process. Additionally, upon completion of the clinical practice 
guideline, the doctoral team used the AGREE II tool to assist with evaluation of the 
validity and completeness of the clinical practice guideline. Completion of the AGREE 
II tool appraisal and the results confirmed the strength of the clinical practice guideline. 
The development of the clinical practice guideline was solely for the utilization of this 
project and no implementation plans exist.  
Strengths and Limitations of the Project 
 The clinical practice guideline has several strengths. A major strength of the 
project is the robust research review completed to elicit the information entered into the 
clinical practice guideline. The research review and clinical practice guideline creation 
were completed with a review of more than one dozen organizational publications and 
evidence-based practice research articles. Many of the recommendations of the clinical 
practice guideline are strong and supported by numerous research findings. Additionally, 
the research was reviewed and graded using a recognized research grading tool, the 
Oxford Centre for Evidence-based Practice Levels of Evidence. Therefore, the research 





 The utilization of the interdisciplinary team for assessment of the clinical practice 
guideline is a major strength of the clinical practice guideline. As identified in the  CCM 
(Zuccaro, 2015) and works by Grover and Joshi (2014), diabetes is a disease best treated 
by an interdisciplinary team. The team members most closely effected by and most likely 
to play a role in postoperative management would include an array of professionals from 
the orthopedic, endocrinology, and diabetes education team. Therefore, using the expert 
opinions of these clinicians as well as having the clinical practice guideline reviewed by 
these individuals allows for assurance that (a) the guideline coincides with the 
recommendations of the specialties, (b) the clinicians believe the clinical practice 
guideline is valid, (c) the clinical practice guideline may have validity for utilization, and 
(d) all specialties understand the problem and agree with a potential practice change.        
 Although the clinical practice guideline does offer several strengths, some 
limitations are noted as well. The first limitation is the limited research pertaining 
specifically to glycemic control postoperatively following an orthopedic procedure. A 
number of postoperative glycemic control research articles have been published, but few 
works were specifically tailored to orthopedic procedures. The findings of these research 
studies may have some differences if performed on a patient group following orthopedic 
surgeries. To combat this, I urge researchers to conduct studies specifically following 
patients living with diabetes requiring an orthopedic surgery. The second disadvantage to 
the clinical practice guideline is the simple fact that postoperative glycemic control is 





efforts to obtain glycemic control postoperatively, if an appropriate treatment algorithm is 
not implemented prior to the orthopedic surgical procedure, attainment of glycemic 
control following the procedure may not be possible. To lessen this disadvantage, 
education should be provided to all parties to ensure the importance of preoperative 
glycemic control is known.   
Summary 
 Based on the identified diabetes epidemic and consequences of poor glycemic 
control both preoperatively and postoperatively, creation of a clinical practice guideline 
was warranted. The clinical practice guideline was created with knowledge of the 
importance of preoperative glycemic control to assist with management of postoperative 
outcomes and postoperative glycemic control. To ensure the clinical practice guideline 
was well-founded, high quality literature   and organizational guidelines were used to 
create recommendations. Further, the doctoral project team, which included experts to 
review the draft clinical practice guideline, applied the AGREE II tool to solidify the 
validity of the recommendations. Clinician use of a synthesized clinical practice guideline 
may improve postoperative glycemic control and decrease the negative consequences of 
poor postoperative glycemic control, specifically following an orthopedic surgery 






Section 5: Dissemination Plan 
Introduction 
 The initial need for the clinical practice guideline development was based on the 
local finding of poor postoperative outcomes related to poor glycemic management 
postoperatively, specifically following orthopedic procedures. From there, I reviewed 
evidence-based research to determine the extent of complications related to poor 
postoperative glycemic control. From the literature, researchers found poor glycemic 
control led to postoperative complications, including extended hospital stays, increased 
risk of infection, delayed return to normal activities of daily living, and even mortality 
among others (Paul & Isaac, 2018). Additional research was compiled to analyze the 
degree of glycemic control needed to ensure a reduction of postoperative outcomes. 
Underwood et al. (2014) found patients had a decreased risk of postoperative 
complications if A1C was less than 8% prior to surgery and even better outcomes if the 
A1C was 6.5% or less. For this project, a decision was made to create a clinical practice 
guideline to assist with postoperative glycemic control following an orthopedic surgery 
requiring hospitalization.  
 As the problem identified was local, dissemination to the local organization is 
warranted. As the published research solidified the importance of preoperative and 
postoperative glycemic control, dissemination of the clinical practice guideline would 
target nursing professionals caring for the patient both preoperatively and postoperatively 





working in endocrinology, diabetes education, and orthopedics, and could be extended to 
the family practice environment. Postoperatively, the audience for this guideline would 
include surgical nurses, inpatient orthopedic nurses, and hospitalist nurses. The practice 
guideline could also be used by physicians and physicians’ assistants.   
 Many stakeholders would be needed to disseminate the guideline and they are part 
of the DNP project team. They include members of the endocrinology, orthopedic, and 
diabetes education teams. These team members hold positions within the local healthcare 
system that afford them the ability and opportunity to meet with policy makers to 
disseminate the guideline into local policy. Generally, the local healthcare system would 
create a task force to review the need for the policy, the validity of the policy, and the 
ability to assimilate the policy into practice. After this is done, one person would be 
responsible for notifying all employees of policy changes and additions.  
Analysis of Self 
 Creation of the clinical practice guideline and project completion required that I 
view myself in varying roles including as a practitioner, scholar, and project manager. 
The project has allowed me to grow in a variety of ways and did present some challenges. 
First, my role as a nurse practitioner allowed me the insight and knowledge of the noted 
problem with glycemic management postoperatively, specifically following an 
orthopedic procedure requiring a hospitalization. In my practice, I had seen firsthand the 
complications associated with poor glycemic control postoperatively. This afforded me 





 After problem identification, I was able to act as a scholar. My education and 
understanding of the field of research allowed me to identify a number of credible 
resources. These resources were the basis of the clinical practice guideline development. 
Prior to that, the resources helped me to understand and share the great impact poor 
glycemic control may have on the surgical patient living with type 2 diabetes. This 
research also allowed me to share the validity of the problem with my project team.  
 As project manager, I gained insight on how to work within a team. I gained 
perspective on leadership and team membership. Although many courses have taught me 
the importance of teamwork in healthcare whether the goal be working in an 
interdisciplinary team for patients or working in a team to offer policy creation or change, 
my professional career had not yet afforded me the opportunity to truly work as a team 
member with the purpose of changing a process within the healthcare system. 
Additionally, as I was the leader of this team, I was able to implement learned leadership 
behaviors and gain a better understanding of the necessary skills leaders must possess in 
order to work as a true team member.  
Taking the leadership role was likely the biggest challenge for me. I am 
accustomed to working as a team and acting as a team member, however, prior to this 
project, I had not been identified as a team leader officially. The leadership role certainly 
comes with expectations and the need for very effective communication. For project 
completion, I worked with individuals in several specialties. Each specialty self-identified 





importance, from a diabetes education perspective ensuring the patient is educated and 
able to self-manage is imperative, and from an orthopedic perspective, ensuring the 
patient receives the necessary procedure to prevented a worsened problem is top priority. 
As a leader, I had to ensure all of these top priorities were placed at the forefront all while 
managing the best interest of the patient and the intent of the project. This project has 
allowed me to grow as a nurse practitioner, scholar, team member, and leader and these 
critical skills will allow me to improve my abilities to grow, learn, and lead throughout 
my career.  
Summary 
 The intent of this project was to create a clinical practice guideline that could be 
easily implemented to improve glycemic control postoperatively, specifically following 
an orthopedic surgery. The created clinical practice guideline outlines the essential steps 
required to ensure postoperative glycemic control. As written, the clinical practice 
guideline is inclusive and allows providers and nurses the ability to advocate for their 
patients to ensure their physical, emotional, and educational needs are met. The clinical 
practice guideline serves the purpose of a clinical practice guideline and may assist with 
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 Diabetes affects 30.3 million Americans and 9.4% of the United States population 
as of 2015 (American Diabetes Association, [ADA], ( 2019a). The prevalence rate 
continues to increase and the annual cost of diabetes was estimated to be $327 billion as 
of 2017 (ADA, 2019a). Type 2 diabetes is a complex disease that has eight noted body 
disruptions known as the ominous octet (DeFronzo et al., 2013). The dysfunctions occur 
at the brain, gut, pancreas, liver, and kidneys and contribute to a diabetes diagnosis 
(DeFronzo et al., 2013). Because of the many body dysfunctions, it is often necessary to 
use multiple medications and an intense treatment algorithm to combat hyperglycemia 
and to achieve adequate glycemic control (ADA, 2019b).  
 The achievement of adequate glycemic control is imperative for the prevention of 
complications. Uncontrolled diabetes can lead to both microvascular and macrovascular 
complications (Hayfron-Benjamin et al., 2019). These complications may include heart 
attack, heart disease, vascular disease, and strokes (Hayfron-Benjamin et al., 2019). 
Additionally, nephropathy, retinopathy, and neuropathy are common complications seen 
with uncontrolled diabetes (Hayfron-Benjamin et al., 2019). Hyperglycemia has also 
been correlated to dementia, depression, and decreased quality of life (Funnell, 2006; 
Simo, Ciudin, Sino-Servat, & Hernandez, 2017). The complications of diabetes may 
contribute to physical, mental, and psychological abnormalities (Hayfron-Benjamin et al., 





 The need for surgical procedures presents special challenges to the patient living 
with type 2 diabetes. First, patients living with type 2 diabetes have an increased need for 
orthopedic surgeries related to average age of diagnosis, the medications effect on bone 
health, and the comorbidities and complications of diabetes (Lee et al., 2016; 
Sundararaghavan, Mazur, Evans, Liu,  & Ebraheim, 2017). Patients living with type 2 
diabetes are at risk for surgical complications including infection, evisceration, poor 
healing, prolonged hospital stay, inadequate and untimely return to work and previous 
lifestyle, as well as mortality (Yong et al., 2018). Both preoperative and postoperative 
glycemic control appear to have an effect on the risk of surgical complications (Garg et 
al., 2016; Yong et al., 2018).  
 As diabetes incidence continues to grow and the knowledge of the complications 
and cost of the illness have spread, a variety of organizations have issued guidelines to 
assist with the management of type 2 diabetes. The ADA (2019a) issues yearly 
recommendations on the management of diabetes throughout varying phases of life, 
including during hospitalization and postoperatively. The American Association of 
Clinical Endocrinologists (AACE, 2019) and the American College of Endocrinology 
(ACE) joined together to publish a type 2 diabetes treatment algorithm. The Endocrine 
Society established a practice guideline for the management of diabetes during 
hospitalization (Umpierrez et al., 2012). In addition to these published guidelines, 





glycemic control postoperatively as well as potential procedures to improve postoperative 
glycemic control.     
 The established guidelines are lengthy and often surround the medical 
management of diabetes. Funnell (2006) published the results of the Diabetes Attitudes, 
Wishes, and Needs Study that surveyed patients living with diabetes and caregivers of 
patients living with diabetes to determine the impact of the disease on the daily life of the 
individual living with the disease. The researchers determined that diabetes had a great 
impact on the patient’s life from a psychological stance (Funnell, 2006). Azani et al. 
(2018) wrote of the correlation between disease distress and lack of psychological well-
being to poor glycemic control. This was established and discussed by Armani Kian et al. 
(2018). Therefore, to improve glycemic control following an orthopedic procedure 
requiring hospitalization in a patient living with type 2 diabetes, it is important to have a 
guideline that clearly and concisely depicts the treatment algorithm which should include 
efforts to enhance the psychological well-being of the patient living with diabetes.  
 A review of the current literature and guidelines shows the vast importance of 
preoperative glycemic control in order to obtain postoperative glycemic control 
(Underwood, Askari, Hurwitz, Chamarthi, & Garg, 2014). Underwood et al. (2014) 
recommend an A1C of 8% or less prior to surgery at a minimum with A1C of 6.5% or 
less for optimal postoperative glycemic control and outcomes. Suboptimal glycemic 





patient outcomes (Yong et al., 2018). Because of this, it is vital to include preoperative 
glycemic control recommendations in this clinical practice guideline.  
The purpose of this clinical practice guideline is to: 
1. Create a clinical practice guideline that is concise, evidence-based, and easily 
implementable. 
2. Focus on improvement of the negative health consequences of type 2 diabetes 
postoperatively. 
3. Create an understanding of the importance of preoperative glycemic control 
for postoperative glycemic control.  
4. Ensure self-management and self-efficacy are addressed during the care of the 
patient with type 2 diabetes. 
5. Ensure appropriate and adequate assessment and management of 
psychological distress is completed. 
Stakeholder Involvement and Clinical Practice Guideline Development: 
This clinical practice guideline was developed using the guidelines and 
recommendations of several professional organizations including ADA (2019a), AACE 
(2019), and several works of high-quality research. The medical recommendations, 
current guidelines, and research on preoperative glycemic control, postoperative 
glycemic control, patients living with type 2 diabetes perspectives and needs, were also 
used. The evidence on self-management, self-efficacy, and psychological distress were 





Additionally, the clinical practice guideline was reviewed in its entirety and graded using 
the AGREE II tool by two endocrinologists, an orthopedic surgeon, an orthopedic nurse, 
two endocrinology nurses, and two diabetes educators.  
Sustainability: 
The clinical practice guideline should be reviewed and amended annually by the 
organizational policy review board. The guideline should be updated based on high 




















 The recommendations were graded using the Oxford Centre for Evidence-Based 
Medicine Levels of Evidence (2011). The Oxford Centre for Evidence-Based Medicine 
Levels of Evidence (2011) ranks sources of literature based on strength of study. 
Additionally, the literature ranking is easily transferrable to a grading recommendation 
using the Oxford Centre for Evidence-Based Medicine Grading Recommendation Guide. 
The grades provided for recommendation range from A through D with a 
recommendation grade of A holding the strongest recommendation and recommendation 
grade D holding the weakest recommendation.  
Questions:  
The following questions acted as a guide for the Clinical Practice Guideline Development 
and focused on the important role of the nurse, patient’s self-efficacy and self-
management skills, as well as the importance of the patient’s psychological status for 
diabetes management. 
1. What effect does preoperative, intraoperative, and postoperative glycemic 
control have on postoperative outcomes? 
2. What is the effect of diabetes self-management education on glycemic 
control? 
3. What is the effect of psychological distress and disease distress on glycemic 
control? 





5. What is the treatment algorithm for glycemic control postoperatively? 
6. When should an individual receive psychological assistance due to diabetes 
distress? 
Target Population: 
Adults aged 18 and older living with a type 2 diabetes diagnosis who have undergone an 
orthopedic surgical procedure requiring hospitalization. 
Preoperative Measures 
 A1C values of 8% and higher were attributed to poor surgical outcomes which 
included longer duration of hospitalization when compared to patients living with 
diabetes with a preoperative A1C of 6.5% or less (Underwood et al., 2014). Akiboye and 
Rayman (2017) cite increased length of stay and increased risk of pulmonary embolism 
in patients living with diabetes with an A1C greater than 6.5% having cervical 
laminoplasty and increased risk of mortality with an A1C greater than 7% in patients 
receiving joint arthroplasty. Asida, Atallia, Gad, Eisa, and Mohamed (2013) found 
hyperglycemia prior to surgery places patients living with diabetes at an increased risk 
for infection, stroke, heart block, and death. Additionally, patients with well-maintained 
preoperative and intraoperative blood sugars, greater than 100 were at a 34% higher risk 
of postoperative complications for every 20 points blood sugar is above target (Asida et 
al., 2013). Therefore, attention to preoperative glycemic control is important (Penrose & 





Sudhakaran and Surami (2015) offer recommendations to ensuring improved 
glycemic control pre, intra, and postoperatively which include the need for frequent 
glucose monitoring and review, medical management strategies, and the need to rule out 
current complications of hyperglycemia including diabetic ketoacidosis (DKA), 
hyperglycemic hyperosmolar syndrome (HHS), and electrolyte imbalances. To manage 
diabetes prior to surgery and in general, the AACE (2019) and ACE joint treatment 
algorithm should be used. This algorithm calls for the titration and addition of 
medications until goal glycemic control is achieved (AACE, 2019). This algorithm does 
use medications that may increase the risk of complications such as dehydration and 
DKA, HHS, and these medications should be held prior to surgery to reduce the risk of 
DKA and dehydration (Sudhakaran and Surami, 2015).        
Recommendations for preoperative glycemic control: 
1. A1C should be below 8%, preferably less than 6.5% prior to elective surgery 
to promote positive postoperative outcomes, and to reduce the risk of 
pulmonary embolism, decrease the length of stay, and decrease the risk of 
mortality (Underwood et al., 2014). Grade B 
2. Preoperative glucose goal of 100 is adequate to reduce postoperative 
complication rates (Asida et al., 2013). Grade A 
3. Frequent monitoring of blood sugars should be completed by the patient and 





4. Medication adjustments should be completed following the joint AACE 
(2019) and ACE type 2 diabetes treatment algorithm. Grade D  
5. DKA and electrolyte imbalances should be ruled out prior to surgery 
(Sudhakaran & Surami, 2015). Grade A 
6. Antihyperglycemic medications should be reviewed and any class of 
medications that may contribute to complications including DKA and 
electrolyte imbalances should be discontinued prior to surgery. These 
medications include biguanides, alpha glucosidase inhibitors, 
thiazolidinediones, sulfonylureas, sodium–glucose co-transporter 2 (SGLT2) 
inhibitors, dipeptidyl peptidase-4 (DPP-4) inhibitors, and glucagon like 
peptide 1 (GLP-1) receptor agonists. Grade B 
Rationale: 
Preoperative glycemic control greatly effects postoperative glycemic control and 
outcomes (Underwood et al., 2014). Because of the pathophysiology of the human body, 
when speaking of orthopedic surgeries involving joints, glycemic control is of the utmost 
importance to prevent surgical failures and complications (Akiboye & Rayman, 2017). 
Clinicians, including nurses should be educated and advocate for the patient to ensure 
that (1) the patient and providers are aware of the importance of glycemic control, and 
potential poor outcomes associated with poor control, (2) glycemic control is achieved 
using appropriate guidelines, and (3) the patient’s safety is held at the forefront of 





General Diabetes Management Goals 
The purpose of managing type 2 diabetes is to reduce the complications 
associated with the disease and improve the quality of life of patients living with the 
disease (ADA, 2019a). Both the ADA (2019a) and AACE (2019) offer recommendations 
for diabetes management. The recommendations include blood glucose and A1C targets.  
Goal ADA Guidelines AACE Guidelines 
A1C <7% 
 <8% in elderly, unhealthy 
<6.5% 
Fasting Blood Sugar Level 70-130 <110 




Lifestyle Modifications for the Management of Diabetes 
Type 2 diabetes management requires an array of medical and lifestyle 
contributions to adequately reach optimal glycemic targets. The first step in the treatment 
algorithm is lifestyle modification through dietary, exercise and lifestyle modification 
efforts (ADA, 2019b). AACE (2019) further discusses the needs of lifestyle modification 
to include behavioral modifications. Lifestyle modification has the ability to delay the 
onset of a type 2 diabetes diagnosis or improve the glycemic control following a 





modifications tend to have poorer glycemic control and higher rates of complications 
associated with type 2 diabetes (Azami et al., 2018).  
Recommendations for glycemic control through lifestyle management: 
1. Improve nutrition to maintain or decreased weight (ADA, 2019b). Grade B 
2. Increase physical activity to 150 minutes weekly with two days of strength 
training weekly (ADA, 2019b). Grade B 
3. Improve sleep habits and ensure seven hours of sleep nightly (ADA, 2019b). 
Grade D 
4. Minimize alcohol consumption (ADA, 2019b). Grade D 
5. Avoid or quit using tobacco products(ADA, 2019b). Grade D 
Rationale: 
The ADA (2019a) and AACE (2019) both offer guidance on goal A1C and glucose 
targets. Lifestyle modifications have been shown to improve glycemic control (ADA, 
2019b). As such, clinicians, including nurses, should assist the patient in understanding 
the potential benefits of improving dietary choices, increasing physical exercise, 
improving sleep patterns, and decreasing tobacco and alcohol consumptions to positively 
impact glycemic control (ADA, 2019b). The ADA offers several resources to assist with 
nutrition improvements and two resources may be found below. From a preoperative 
standpoint, these lifestyle modifications assist with the needed improvements in glycemic 
control and decrease the associated risks of postoperative complications related to poor 






What Can I Eat?   |   1-800-DIABETES (1-800-342-2383)   |   diabetes.org/whatcanieat                           
© 2019 American Diabetes Association. 






What Can I Eat?   |   1-800-DIABETES (1-800-342-2383)   |   diabetes.org/whatcanieat           
© 2019 American Diabetes Association. 
Excerpted from American Diabetes Association Patient Education Materials (2019). 
What Can I Eat? Page 1-2 
Medications 
When A1C is elevated despite lifestyle modification, medication initiation is 
recommended following an algorithm (AACE, 2019). The AACE and ACE published a 
medication initiation and titration algorithm to assist with treatment plan creation for 







 All fats are high in calories, so keep the portion size small (less than 1 
 
This fist = 1 My fist = _____ Your fist is a handy tool 
always with you. Place your 
the outline to the right to see 
compares to a measuring 
Healthy 
Choose low-cost recipes and meals. 
ingredients are often cheaper and quick 
to look for diabetesfoodhu. 
Avocado, olives, seeds, 













 Oil-based salad dressing: 
 oil and 
 
Low-fat creamy salad 
 like light 
 
Full-fat creamy salad 














medications to achieve optimal glycemic control (ADA, 2019a). Medications used to 
treat hyperglycemia in  patients living with type 2 diabetes have different mechanisms of 
action and assist with glycemic control in a variety of ways (AACE, 2019). Therefore, it 
is important to understand the pharmacodynamics and pharmacokinetics of each 
medication to ensure improved glycemic control will result (ADA, 2019a). Though 
specialized providers are knowledgeable on the disease states and medications used for 
diseases, providers of non-specialty origin with extensive knowledge on the specific 
disease may be an effective resource as well (Reategui et al., 2015). Additionally, 
Sabione, Cavalot, Paccotti, Massucco, and Vigna-Taglianti (2018) found little difference 
in patient outcomes when patients were treated in a specialty office versus a care 
management team approach. If the treatment algorithm is correct, patients are compliant 
and have adequate self-efficacy, the outcomes will follow (Sabione et al., 2018).  
Recommendations for pharmacologic management of glycemic control: 
1. Use the AACE/ACE medication algorithm for pharmacologic 
management of type 2 diabetes (AACE, 2019). Grade D 
2.  Use the AACE/ACE insulin titration algorithm for improved glycemic 
control for individuals on insulin therapy (AACE, 2019). Grade D 
3. Use resources from the ADA to improve knowledge and understanding of 








The joint AACE/ACE (2019) algorithm was developed using extensive expert opinion 
and has been continually revised to adapt to the latest pharmacologic advancements and 
knowledge from diabetes research. Clinicians and nurses should ensure medication 
adjustments are made or advocated for based on the most recent findings to promote 
glycemic control. Again, achieving glycemic control prior to orthopedic surgery 










Excerpted from AACE/ACE Comprehensive Type 2 Diabetes Algorithm. (2019).  
Diabetes Education, Self-Management, and Self-Efficacy 
Diabetes education is warranted during the early stages of disease progression to 
enhance knowledge and self-management skills (ADA, 2019a). Continued diabetes 
education with an emphasis on self-management and self-efficacy is vital (Van 
Smoorenburg et al., 2019). Self-management ability contributes to improved patient 
outcomes (Janiszewski, O’Brien, & Lipman, 2015). Type 2 diabetes requires the attention 
and decision making skills of the patient, thus, the patient must be self-reliant and have 





As the patient progresses through life or changes to health status, economic status, or 
activities of daily living change, additional education and support opportunities should be 
made available to the patient (Warshaw et al., 2019). Additionally, yearly educational 
reviews have proven beneficial (Warshaw et al., 2019). Diabetes education programs 
should be individualized to meet each and every patients needs (Van Smoorenburg et al., 
2019).  
The American Association of Diabetes Educators (AADE, 2020) is a great 
resource for healthcare professionals and patients living with diabetes alike. The 
organization established the seven self-care behaviors as follows: (a) “healthy eating, (b) 
being active, (c) monitoring, (d) taking medication, (e) problem-solving,( f) reducing risk, 
and (g) healthy coping” (AADE, 2020). Additionally, the AADE in conjunction with the 
CDC follow the standards for diabetes self-management education when developing 
educational programs (Beck, Greenwood, & Blanton, 2017). The standards are reviewed 
and updated to ensure superior development of educational programs and improved 
patient outcomes (Beck et al., 2017). 
10 National Standards for Diabetes Self-Management Education: 
1. The program should be sustained within an organization and follow goals 
and a mission set forth by the organization (Beck et al., 2017).  
2. Experts in the field and stakeholders shall evaluate the program to ensure 





3. The program should be accessible and created with the lifestyle of the 
community in mind (Beck et al., 2017). 
4. The quality and rigor of the program shall be assessed by one individual 
responsible entirely for ensuring the program follows the standards, 
remains relevant, evidence-based, and appropriate (Beck et al., 2017).  
5. The education team must include one registered nurse, dietitian, 
pharmacist, or other individual with a current certified diabetes educator 
license or advanced diabetes board management certification (Beck et al., 
2017).  
6. The educational material should be relevant, up to date, research and 
evidence based (Beck et al., 2017).  
7. The program shall not be so structured so that the individual patient needs 
are ignored or overshadowed. Education should be personalized (Beck et 
al., 2017). 
8. Education shall include continued education opportunities and ways to 
receive continued support (Beck et al., 2017).  
9. Participants should identify personal goals that shall be evaluated through 
the educational experience (Beck et al., 2017). 
10. Quality and patient outcomes should be assessed and reviewed with 





Recommendations for diabetes self-management, self-education, and self-efficacy for 
improved glycemic control:  
1. Use resources including the AADE website to locate and refer patients to 
diabetes education (AADE, 2019). Grade D 
2. Reinforce diabetes education teaching with patient interaction (Beck et al., 
2017). Grade D 
3. Monitor patients for self-management and self-efficacy skill (AADE, 
2019). Grade D 
4. Consider referring patients to diabetes education at diagnosis. on a yearly 
basis and as life circumstances change (AADE, 2019). Grade D 
5. Educate patient on support and education resources such as ADA website 
and AADE website (Beck et al., 2017). Grade D 
6. Incorporate self-care behavior education into patient interaction (AADE, 
2019). Grade D 
Rationale: 
Diabetes requires the ability of the patient to self-manage and use self-efficacy (AADE, 
2019). Diabetes education programs that improve the patients’ ability to self-mange and 
improve self-efficacy behaviors allow for improved glycemic control (Beck et al., 2017). 
Clinicians including nurses should contribute to the patients’ education levels and be 





contribute to improved glycemic control preoperatively and better patient outcomes 
postoperatively (Underwood et al., 2014).  
Psychological Impact 
The psychological impact of living with diabetes should not be understated. The 
initial Diabetes Attitudes, Wishes, and Needs (DAWN) study explored the psychological 
implications of life with diabetes (Funnell, 2006). Participants from 13 countries were 
questioned in regard to disease distress and impact of living with diabetes on their daily 
life (Funnell, 2006). The study findings determined high rates of diabetes distress for 
patients living with a diabetes diagnosis (Funnell, 2006). Additionally, healthcare 
providers caring for individuals with diabetes also felt the burden of the disease (Funnell, 
2006). Because diabetes distress and living with diabetes is a psychological burden on the 
patient and caregivers the psychological feelings should be treated to ensure quality of 
life (Funnell, 2006). 
The DAWN 2 study further solidified the findings of the initial DAWN study 
(Joensen et al., 2017). The study surveyed individuals living with diabetes as well as 
caregivers and family members in 17 countries to ascertain the emotional effects of life 
with diabetes (Joensen et al., 2017). An impressive 15,000 participants were surveyed 
with similar findings when compared to the DAWN study (Joensen et al., 2017). Nearly 
half of the participants living with diabetes admitted to diabetes distress (Joensen et al., 
2017). Disease distress and stress in general may contribute to impaired glycemic control 





improve glycemic control, improve quality of life, and improved psychological wellbeing 
(Armani Kian et al., 2018). The DAWN and DAWN 2 (Funell, 2006; Joensen et al., 
2017) studies as well as the research of Armani Kian et al. (2018) suggest a correlation 
between diabetes distress and poor glycemic control. Therefore, patients should be asked 
about their level of distress and their psychosocial health should be assessed (ADA, 
2019b). 
Diabetes distress and depression are two separate diagnoses. Similarly to diabetes 
distress, depression has been positively correlated to a diabetes diagnosis (Egede, Bishu, 
Walker, & Bismuke, 2016). Depression also plays a role in the patients quality of life as 
well as effects self-care and self-management (Egede et al., 2016). Depression as a 
comorbidity is associated with increased healthcare expenditure as well (Egede et al., 
2016). It is important to screen for both diabetes distress and depression in patients with a 
diabetes diagnosis. The PHQ-9 is a patient questionnaire used to assess patients level of 
depression (University of Washington, 2020).  
Recommendations for psychological management in the patient with type 2 diabetes 
contributing to improved glycemic control: 
1. Patients living with diabetes should be screened for depression using an 
approved and reputable screening tool such as the PHQ-9 tool (AADE, 
2019). Grade D 
2. Patients living with diabetes should be assessed for disease distress such 





3. Patients should be referred to a mental health provider if screening for 
depression or disease distress is positive (ADA, 2019b). Grade D 
4. Patients should be referred to diabetes self-management education when 
appropriate to enhance self-management and self-efficacy skills and to 
decrease disease burden (Beck et al., 2017). Grade D 
Rationale: 
Both diabetes distress and depression have negative consequences and lead to poor 
glycemic control (Egede et al., 2016; Joensen et al., 2017). It is imperative for clinicians, 
including nurses to understand the potential negative effects of depression and distress on 
the patient living with type 2 diabetes. It is also important for clinicians, including nurses 
to understand the high rates of disease distress and depression seen in patients living with 
diabetes (Egede et al., 2016). Because diabetes distress and depression negatively impact 
glycemic control, preoperative patients especially should be screened for these disorders 
to ensure good preoperative and postoperative glycemic control.  
Nurses Role 
 Nurses are uniquely positioned in the healthcare industry and this position affords 
the profession optimal access to assist patients with chronic disease (Stuij et al., 2019). 
Researchers have found that using a team approach to assist with type 2 diabetes 
management when the team involves a nurse allows for improved glycemic control and 
patient empowerment (Janiszewskin et al., 2015). Additionally, shared medical 





with type 2 diabetes, led by nurses resulted in improved patient empowerment (Davis, 
Johnson, McClory, & Warneck, 2019). Garg et al. (2016) wrote of the positive outcomes 
seen following a nurse practitioner led diabetes management program. Following the 
introduction of a program led by nurse practitioners to assist with glycemic control, 87% 
of participants reached glycemic target as noted by A1C value (Garg et al., 2016). The 
research conducted by Stuij et al. (2019) found nurse-patient relationships were best 
cultivated outside of a clinical space. Community based activities may lead to improved 
nurse-patient relationships, therefore, improved glycemic control (Stuij et al., 2019). 
Recommendations for nurses to assist with improvement of preoperative glycemic 
control: 
1. The nurse-patient relationship should be cultivated to engage patients and 
assist with the improvement of glycemic control and patient outcomes 
(Garg et al., 2016). Grade B 
2. Nurses should be included in the team approach for diabetes management 
(Janiszewskin et al., 2015). Grade B 
3. Shared medical appointments led by nurses may be considered to assist 
with patient empowerment and glycemic outcomes (Davis et al., 2019). 
Grade B 
4. Nurse practitioners offer a great resource to patients and may assist with 
glycemic control, therefore, should be used as appropriate per licensure 





5. Community based programs that allow patients to interact and receive 
education from nurses outside of a clinical space should be considered 
(Stuij et al., 2019). Grade D 
Rationale: 
Nurses hold a powerful role in the patient-care experience and have the ability to 
influence care and outcomes in a unique way (Stuij et al., 2019). Additionally, nurse 
practitioners have the ability to continue the positive patient-nurse relationship and 
provide high quality patient care (Garg et al., 2016). Achieving glycemic control 
preoperatively requires attention and time that may be an interdisciplinary team including 
a nurse and nurse practitioner (Davis et al., 2019). Achievement of glycemic control 
preoperatively requires intense management, support, and decision making, therefore, 














Intraoperative Glycemic Control 
Glycemic control during an orthopedic surgical procedure should be monitored 
closely as intraoperative glucose level also play a role in postoperative outcomes (Asida 
et al., 2013). Researchers found that more intensive glycemic control during surgery 
translated to fewer negative outcomes and postoperative complications when compared to 
a blood sugar target of greater than 180 (Asida et al., 2013). Glycemic control may be 
achieved using the guideline for treatment of diabetes during hospitalization (ADA, 
2019b).    
Recommendations for intraoperative glycemic control: 
1. Monitor glucose levels frequently during surgery (Asida et al., 2013). Grade A 
2. Use the ADA guidelines to appropriately manage glucose levels during 
hospitalization (ADA, 2019b). Grade D 
3. Keep blood sugar between 100 and 180 during surgical procedure to improve 
patient outcomes and decrease the risk of postoperative complications (Asida 
et al., 2013). Grade A 
Rationale: 
Just as noted with preoperative glycemic control, intraoperative glycemic control must be 
achieved in order to achieve postoperative glycemic control (Aside et al., 2013). 
Additionally, poor glycemic control intraoperatively leads to a multitude of 





For the patient undergoing orthopedic surgery, intraoperative control should be achieved 
























Postoperative Glycemic Control 
 Postoperative control relies heavily on preoperative and intraoperative control 
(Penrose & Lee, 2013). Akiboye and Rayman, 2017 published research correlating 
postoperative complications to perioperative glycemic control. Lee at al. (2016) found 
blood sugars remain elevated for months postoperatively, significantly impacting the 
daily life, perceptions of quality of life, and health outcomes of the patient living with 
type 2 diabetes. Guidelines suggesting appropriate care approaches postoperatively and 
during hospitalizations have been published by the ADA (2019 a), the AACE (2019) as 
well as the Endocrine Society (Umpierrez et al., 2012). These recommendations are 
lengthy and intricate, therefore, may not be followed appropriately. To improve 
postoperative glycemic control, a synthesis of the organizational guidelines and 
recommendations has been created to allow for ease of use with the aim of improving 
patient outcomes in terms of glycemic control and reduction of complications associated 
with glycemic imbalances postoperatively.  
Treatment Recommendations during hospitalization: 
1. An A1C should be checked on all patients with known diabetes if one has 
not been performed in the last 3 months and also for all individuals with a 
blood sugar level above 140 (ADA, 2019b). Grade D 
2. Though a sliding scale should not be used solely, a correction scale should 
be ordered in order to correct hyperglycemia in addition to a basal insulin 





3. A combination of basal, prandial, and correction insulin is recommended 
for glycemic control during hospitalization (ADA, 2019b). Grade A 
4. Diabetes education, endocrinology, or other specialized care provider 
should be consulted to assist with glycemic management (ADA, 2019b). 
Grade D 
5. Insulin therapy should begin with a blood glucose level above 180 (ADA, 
2019b). Grade A 
6. Blood glucose level targets should be 140-180 for most individuals, 110-
140 if the patient is able to tolerate and is not on a critical care unit (ADA, 
2019b). Grade B 
7. Blood sugar should be checked at bedside before meals and at bedtime for 
patients eating (ADA, 2019b). Grade D 
8. Blood sugars should be checked every four to six hours for patients unable 
to eat (ADA, 2019b). Grade D 
9. Hypoglycemia in the hospital setting shall be defined as any blood sugar 
reading less than 70 (ADA, 2019b). Grade B 
10. If a patient has a hypoglycemia event, the pre-established hypoglycemia 
protocol should be initiated (ADA, 2019b). Grade B 
11. The insulin regimen should be decreased if a hypoglycemia event occurs 





12. Diabetes education and medical nutrition therapy consults should be 
placed on an as needed basis (ADA, 2019b). Grade D 
13. A comprehensive discharge plan shall be established prior to hospital 
discharge  
(ADA, 2019a). Grade B 
Rationale: 
Glycemic control in the hospital postoperatively is important to decrease the risk of 
postoperative complications following an orthopedic procedure (ADA, 2019b; 
Underwood et al., 2014). The ADA (2019b) has published established guidelines for the 
management of glycemic control during hospitalization. These guidelines aim to 
eliminate hypoglycemia while controlling blood glucose adequately (ADA, 2019b). 
Clinicians, including nurses can use these recommendations as well as the preoperative 
glycemic control recommendations including the medication algorithms to advocate for 
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